US20060155323A1 - Intra-aneurysm devices - Google Patents

Intra-aneurysm devices Download PDF

Info

Publication number
US20060155323A1
US20060155323A1 US11/031,421 US3142105A US2006155323A1 US 20060155323 A1 US20060155323 A1 US 20060155323A1 US 3142105 A US3142105 A US 3142105A US 2006155323 A1 US2006155323 A1 US 2006155323A1
Authority
US
United States
Prior art keywords
aneurysm
members
central member
lower member
central
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/031,421
Inventor
Stephen Porter
Tri Tran
Hahn Ho
Thach Cao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stryker European Operations Holdings LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36121387&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20060155323(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to US11/031,421 priority Critical patent/US20060155323A1/en
Application filed by Individual filed Critical Individual
Assigned to BOSTON SCIENTIFIC SCIMED, INC. reassignment BOSTON SCIENTIFIC SCIMED, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CAO, THACH, HO, HAHN, PORTER, STEPHEN CHRISTOPHER, TRAN, TRI D.
Priority to PCT/US2005/047349 priority patent/WO2006074032A2/en
Publication of US20060155323A1 publication Critical patent/US20060155323A1/en
Assigned to STRYKER CORPORATION, STRYKER NV OPERATIONS LIMITED reassignment STRYKER CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BOSTON SCIENTIFIC SCIMED, INC.
Priority to US13/887,589 priority patent/US10265075B2/en
Assigned to STRYKER MEDTECH LIMITED reassignment STRYKER MEDTECH LIMITED NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER NV OPERATIONS LIMITED
Assigned to STRYKER EUROPEAN HOLDINGS I, LLC reassignment STRYKER EUROPEAN HOLDINGS I, LLC NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER MEDTECH LIMITED
Assigned to STRYKER MEDTECH LIMITED reassignment STRYKER MEDTECH LIMITED CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL # 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0034. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT. Assignors: STRYKER NV OPERATIONS LIMITED
Assigned to STRYKER EUROPEAN HOLDINGS I, LLC reassignment STRYKER EUROPEAN HOLDINGS I, LLC CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT LISTED SERIAL NOS. 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0241. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 9/29/2014. Assignors: STRYKER MEDTECH LIMITED
Priority to US16/389,168 priority patent/US20190298379A1/en
Assigned to STRYKER EUROPEAN HOLDINGS III, LLC reassignment STRYKER EUROPEAN HOLDINGS III, LLC NUNC PRO TUNC ASSIGNMENT (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER EUROPEAN HOLDINGS I, LLC
Assigned to STRYKER EUROPEAN OPERATIONS HOLDINGS LLC reassignment STRYKER EUROPEAN OPERATIONS HOLDINGS LLC CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: STRYKER EUROPEAN HOLDINGS III, LLC
Priority to US17/022,037 priority patent/US20210052279A1/en
Priority to US17/950,660 priority patent/US20230015848A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • A61B17/12109Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel
    • A61B17/12113Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder in a blood vessel within an aneurysm
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B2017/1205Introduction devices
    • A61B2017/12054Details concerning the detachment of the occluding device from the introduction device
    • A61B2017/12063Details concerning the detachment of the occluding device from the introduction device electrolytically detachable

Definitions

  • compositions and methods for repair and treatment of aneurysms are described.
  • devices and systems for placement in an aneurysm are disclosed, as are methods of making and using these devices.
  • An aneurysm is a dilation of a blood vessel that poses a risk to health from the potential for rupture, clotting, or dissecting. Rupture of an aneurysm in the brain causes stroke, and rupture of an aneurysm in the abdomen causes shock. Cerebral aneurysms are usually detected in patients as the result of a seizure or hemorrhage and can result in significant morbidity or mortality.
  • vaso-occlusion devices are surgical implements or implants that are placed within the vasculature of the human body, typically via a catheter, either to block the flow of blood through a vessel making up that portion of the vasculature through the formation of an embolus or to form such an embolus within an aneurysm stemming from the vessel.
  • vaso-occlusive device is a helical wire coil having windings that may be dimensioned to engage the walls of the vessels.
  • Vaso-occlusive coils having little or no inherent secondary shape have also been described.
  • co-owned U.S. Pat. Nos. 5,690,666; 5,826,587; and 6,458,119 by Berenstein et al. describes coils having little or no shape after introduction into the vascular space.
  • U.S. Pat. No. 5,382,259 describes non-expanding braids covering a primary coil structure.
  • wide neck aneurysms are those in which the neck (the entrance zone) has a diameter that either: (1) is at least 80% of the largest diameter of the aneurysm; or (2) is clinically observed to be too wide effectively to retain vaso-occlusive coils that are deployed using the techniques discussed above. Accordingly, devices for retaining coils within aneurysms have been described. See, e.g., U.S. Pat. No. 6,168,622 and U.S. Patent Application Publication No. 20030195553.
  • this invention includes novel occlusive devices as well as methods of using and making these devices.
  • the invention includes a vaso-occlusive device for placement within an aneurysm having a neck and a dome, the device comprising a lower member having a linear configuration prior to deployment and a deployed open configuration, wherein the deployed configuration bridges the neck of the aneurysm; an upper member having a undeployed, linear configuration prior and an open, deployed configuration, wherein the deployed configuration rests against at least a portion of the dome of the aneurysm, and a means of adjusting the overall dimensions of the device.
  • the distance between the upper and lower members is adjustable.
  • the lower and/or upper member is compressible (e.g., deformable against the wall of the aneurysm).
  • the upper and lower members may be contiguous or alternatively, the upper and lower members may be separate, for example when the device further comprises an adjustable central member having a proximal end connected to the lower member and distal end connected to the upper member.
  • One or more of the upper member lower member and optional central member may be compressible or may comprise a compressible element.
  • the optional central member may further comprise an extendable member connected to the upper member; and/or an expandable element.
  • the upper member may comprise a plurality of axially moveable wires passing through the lumen of the central member, each wire comprising a distal end and a proximal end.
  • the distal end of one or more of the wires is attached to the central member and/or to the lower member.
  • the upper member may be compressible or deformable, for example against the dome of an aneurysm, thereby changing the overall dimensions of the device.
  • the invention includes any of the devices as described herein, which device further comprises one or more detachment junctions, each detachment junction comprising an electrolytically detachable end adapted to detach by imposition of a current thereon.
  • One or more detachment junctions may be positioned between the upper member and a pusher wire and/or between the lower member and a pusher tube.
  • the invention includes any of the devices as described herein, which device further comprises one or more locking mechanisms.
  • the locking mechanism comprises an expandable material, for example a self-expanding element.
  • the invention includes any of the devices as described herein, wherein the upper member comprises a metal, for example, a metal selected from the group consisting of nickel, titanium, platinum, gold, tungsten, iridium and alloys or combinations thereof.
  • the upper member comprises the alloy nitinol.
  • the invention includes any of the devices as described herein, wherein the lower member comprises a metal, for example a metal selected from the group consisting of platinum, palladium, rhodium, gold, tungsten and alloys thereof.
  • the lower member comprises nitinol.
  • the invention includes any of the devices as described herein, wherein the upper and/or lower member comprises a braid or mesh configuration.
  • the lower member comprises a mesh or braid structure.
  • the lower member comprises a film (e.g., a porous film, a polymer film or a metallic film).
  • the invention includes any of the devices as described herein, which device further comprises an additional component, for example a bioactive component.
  • the invention includes a method of occluding a body cavity comprising introducing a vaso-occlusive device as described herein into the body cavity (e.g., an aneurysm).
  • a vaso-occlusive device as described herein into the body cavity (e.g., an aneurysm).
  • FIG. 1 depicts a side-view of an exemplary assembly as described herein having umbrella shaped upper and lower members.
  • a compressible, spring-like central member connects the upper and lower members and adjusts the distance between the upper and lower members.
  • FIG. 2 depicts a side-view of an exemplary assembly as described herein having umbrella shaped upper and lower members.
  • the distance between the upper and lower member can be adjusted by extending or retracting an extendable member located on a central member.
  • the central member connects and extends between the upper and lower members.
  • FIG. 3 depicts a side view of another exemplary assembly as described herein having an umbrella shaped lower member from which a central tubular member extends.
  • the central member may be integral to or separate from the lower member.
  • Upper member comprises a plurality of individual members that extend from and loop back into the central member. Upper member elements are extendable and retractable through the central member.
  • FIG. 4 depicts a side view of another exemplary assembly as described herein having an umbrella shaped lower member from which a central tubular member extends.
  • the central member may be integral to or separate from the lower member.
  • Upper member comprises a plurality of individual members that extend from and the central member. Upper member elements are attached at their distal ends to the lower member and may be extended or retracted through the central member to change the overall dimensions of the device.
  • FIG. 5 panels A and B, are side views depicting another exemplary embodiment in which the upper and lower members comprise a contiguous element.
  • Panel A depicts contiguous upper and lower members connected by a central member that includes a compressible member.
  • Panel B depicts contiguous upper and lower members that are expandable and an expandable central member.
  • FIG. 6 panels A and B, are side views of an exemplary locking mechanism.
  • Panel A depicts the device in an unlocked position in which the distance between upper and lower members can be adjusted.
  • Panel B depicts the locked position in which the distance between the upper and lower members remains fixed. Also shown is detachment junction for releasing the device once the desired configuration is achieved.
  • FIG. 7 panels A and B, are side views of an exemplary locking mechanism.
  • Panel A depicts the device in an unlocked position in which the distance between upper and lower members can be adjusted.
  • Panel B depicts the locked position in which the distance between the upper and lower members remains fixed. Also shown is detachment junction for releasing the device once the desired configuration is achieved.
  • FIG. 8 panels A and B, are side views of an exemplary locking mechanism.
  • Panel A depicts the device in an unlocked position in which the distance between upper and lower members can be adjusted.
  • Panel B depicts the locked position in which the distance between the upper and lower members remains fixed. Also shown is detachment junction for releasing the device once the desired configuration is achieved.
  • FIG. 9 panels A to D, depict exemplary deployment procedure.
  • Panel A depicts the lower portion of the device as it is advanced through the delivery catheter by the pusher wire.
  • Panel B shows expansion of the lower member after extrusion from a constraining member (e.g., pusher catheter and/or sheath).
  • Panel C shows the device after it is locked in place via an expandable material and after the pusher wire has been detached.
  • Panel D shows detachment of the pusher catheter and removal of the pusher and delivery catheters.
  • Occlusive (e.g., embolic) devices are described.
  • the devices described herein find use in vascular and neurovascular indications and are particularly useful in treating aneurysms, for example wide-neck, small-diameter, curved or otherwise difficult to access vasculature, for example aneurysms, such as cerebral aneurysms.
  • Methods of making and using these vaso-occlusive devices also form aspects of this invention.
  • the device is a surgical implement and can be readily deployed, removed and/or repositioned in human vasculature.
  • the devices include a lower member, an upper member and a means for adjusting the overall dimensions of the device, including, for example, a means of adjusting the distance between the lower and upper members.
  • the upper and lower members may be separate or contiguous elements.
  • one or both of the upper and lower members may be compressible.
  • the lower member typically sits in the neck of the aneurysm while the upper member sits against the walls (e.g., dome) of the aneurysm.
  • the upper and/or lower member may be moved in relation to each other (e.g., extended, expanded, compressed, etc.) in order to change the overall dimensions of the device.
  • One or more adjustable elements e.g., a central member
  • an extendable central member connecting the lower and upper members may be included.
  • FIG. 1 device ( 10 ) constructed in accordance with one embodiment of the present invention is shown in a side-view of a deployed position within an aneurysm ( 70 ) of a blood vessel ( 15 ).
  • the aneurysm ( 70 ) is shown with an oppositely disposed neck ( 75 ) and dome ( 85 ).
  • upper ( 20 ) and lower ( 30 ) members have a flared open (umbrella) configuration after deployment that advantageously conforms to the shape of the aneurysm ( 70 ).
  • the diameter of the upper member ( 20 ) is larger than the neck ( 75 ), and thus preferably completely covers the neck ( 75 ) upon deployment. Also shown in FIG.
  • Central member ( 40 ) is central member ( 40 ), which is connected at its distal end to upper member ( 20 ) and at its proximal end to lower member ( 30 ).
  • Central member ( 40 ) also includes a compressible portion ( 50 ) that acts as a spring to adjust the distance between and to transfer force from lower member ( 30 ) to upper member ( 20 ).
  • Central member ( 40 ) may also be extendable.
  • FIG. 2 shows a side view of another variation in which the distance between upper ( 20 ) and lower ( 30 ) members can be adjusted using an extendable member ( 60 ) extending from the distal end of central member ( 40 ). Extendable member ( 60 ) can be extended and retracted from the lumen of the central member ( 40 ) to move the upper ( 20 ) and lower ( 30 ) members closer together or farther apart.
  • the upper member ( 20 ) is attached to the distal end of the extendable member ( 60 ) and the lower member ( 30 ) is attached to the distal end of the tubular central member ( 40 ).
  • movement of the extendable member ( 60 ) can be controlled by any suitable actuator.
  • FIG. 3 shows a side view of another variation in which the overall dimensions are adjusted using an extendable upper member ( 20 ).
  • Upper member ( 20 ) comprises a plurality of moveable elements (e.g., wires or microcoils) that extend from an optional central member ( 40 ).
  • the plurality of extendable members that comprise upper member ( 20 ) form loops as they extend from and back into a lumen in the central member ( 40 ).
  • the distal ends of the wires are shown attached to the central member ( 40 ) while the proximal ends can be extended or retracted by an operator until the device has the desired overall dimensions (e.g., the loop portion abuts the dome of the aneurysm).
  • the wires making up the loops of the upper member may be compressed against the upper wall of the aneurysm upon deployment and thereby change the distance between the uppermost portion of the device and the lower member.
  • FIG. 4 depicts a side view of a variation similar to that shown in FIG. 3 in which the distal ends of the plurality of moveable upper member elements ( 20 ) are attached to the lower member ( 30 ) rather than the central member ( 40 ).
  • the proximal ends can be extended or retracted by an operator, thereby forcing the loop portion against the dome of the aneurysm.
  • the wires may be compressed against the upper wall of the aneurysm upon deployment, thereby changing the overall configuration of the device.
  • FIG. 5 panels A and B, depict another variation in which the upper member ( 20 ) and lower member ( 30 ) are a single structure.
  • Panel A is a side view of an exemplary embodiment in which upper ( 20 ) and lower ( 30 ) members are connected by central member ( 40 ). Central member further comprises a compressible portion ( 50 ) to adjust distance between upper and lower members.
  • Panel B is a side view of an exemplary embodiment in which upper ( 20 ) and lower ( 30 ) members comprise a plurality of wires that can expand the overall diameter of the device.
  • Central member ( 40 ) also comprises an expandable member ( 55 ).
  • the contiguous structure may take any number of forms, including but not limited to, wires (FIG. SB), braided or woven configurations, solid configurations ( FIG. 5A ) and the like. It will be apparent that, as a whole, the materials making up contiguous upper and lower member structures may vary in different portions of the structure. For example, in braided or woven structures, the tightness of the braid or weave may be different in the upper portion as compared to the lower portion. Similarly, different additional components may be used in different portions of a contiguous upper and lower member structure.
  • the overall dimensions of the devices described herein are adjustable, thereby facilitating a transfer of force between the lower member (in the neck) to the upper member (the dome of the aneurysm).
  • the dimensions can be adjusted (and force transferred) in a variety of ways, including but not limited to, the inclusion a moveable central member; a moveable upper member; springs; and/or expandable elements such as balloons.
  • the adjustable nature of the dimension(s) of the devices described herein aid in ensuring that the lower member sits in the neck the aneurysm while the upper member presses safely against the dome of the aneurysm.
  • the area of contact between the upper and the aneurysm wall is maximized so as to distribute the force across the widest possible area and thus exert the least amount of pressure on the aneurysm wall.
  • the devices described herein are capable of retaining finer vaso-occlusive devices (e.g., coils, liquid embolics, etc.) within the aneurysm, they are also capable of functioning as vaso-occlusive devices by themselves.
  • the force-transfer effect achieved by including one or more adjustment means serves to anchor the device in the aneurysm and reinforce the lower member so that it is able to remain stably situated across the aneurysm neck while diverting the flow of blood from within the aneurysm.
  • the devices described herein may conform to a range of shapes and sizes of aneurysms since the dimensions are adjustable.
  • the devices can be sized to fit aneurysms ranging in size from millimeters in diameter to centimeters in diameter. In this way, the operator can select a device of a generally suitable size for the particular indication and adjust it to fit securely by conforming the upper member to the dome of the aneurysm.
  • the lower member and upper members may assume a variety of structures, for example, umbrella, dome, balloon, teardrop or cone shape.
  • the deployed configuration of the lower member is preferably such that it sits in and covers the neck of the aneurysm.
  • the deployed configuration of the upper member is such that it sits safely against the dome of the aneurysm (e.g., back inner wall).
  • the overall structure of the upper member is typically more variable than that of the lower member and includes, but is not limited to, configuration such as umbrella shapes, strings or wires formed into loops, etc.
  • One or both of the lower and upper members may also include thin-film, braided, mesh like or basket type structures.
  • the upper and lower members may be a single element, for example expandable structures, for example as shown in FIG. 5 .
  • Upper and lower members can be constructed from a wide variety of materials, including, but not limited to, metals, metal alloys, polymers or combinations thereof. See, e.g., U.S. Pat. Nos. 6,585,754 and 6,280,457 for a description of various polymers.
  • suitable metals include, Platinum Group metals, especially platinum, rhodium, palladium, rhenium, as well as tungsten, gold, silver, tantalum, stainless steel and alloys of these metals.
  • the lower member comprises a material that maintains its shape despite being subjected to high stress, for example, “super-elastic alloys” such as nickel/titanium alloys (48-58 atomic % nickel and optionally containing modest amounts of iron); copper/zinc alloys (38-42 weight % zinc); copper/zinc alloys containing 1-10 weight % of beryllium, silicon, tin, aluminum, or gallium; or nickel/aluminum alloys (36-38 atomic % aluminum).
  • “super-elastic alloys” such as nickel/titanium alloys (48-58 atomic % nickel and optionally containing modest amounts of iron); copper/zinc alloys (38-42 weight % zinc); copper/zinc alloys containing 1-10 weight % of beryllium, silicon, tin, aluminum, or gallium; or nickel/aluminum alloys (36-38 atomic % aluminum).
  • “super-elastic alloys” such as nickel/titanium alloys
  • Shape memory alloys comprise a unique class of metal alloys that, once trained, are configured to “remember” a pre-selected shape, i.e., deployed shape, and can return to the pre-selected shape even if subsequently reshaped.
  • the shape memory alloy is molded and heated at or above a training, or austenite, temperature to place the shape memory alloy in an austenite phase.
  • the shape memory alloy is formed in the first pre-selected shape and then, once formed, is permitted to cool to a martensite finish temperature, whereupon the shape memory alloy enters a martensite phase.
  • the martensite finish temperature can be any temperature that is less than the training temperature.
  • the shape memory alloy Upon entering the martensite phase, the shape memory alloy has been trained to “remember” the first pre-selected shape. While in the martensite phase, the alloy is in a soft state and is formed into a second pre-selected shape, e.g., an undeployed shape.
  • the shape memory alloy in the martensite phase is configured to maintain the second pre-selected shape and, if subsequently reheated to an activation temperature, automatically returns to the first pre-selected shape.
  • the activation temperature can comprise any temperature that is greater than the martensite finish temperature and generally approximately equals the training temperature.
  • the training, martensite finishing, and activation temperatures for a shape memory alloy are adjustable, depending on the composition.
  • a slight extra amount of Nickel added to a NiTi alloy composition can change the training temperature from approximately 0° C. to 100° C.
  • the lower member may also comprise a shape memory polymer such as those described in International Publication WO 03/51444.
  • the upper and/or lower members of the devices described herein may also be moveable.
  • the upper member may comprise a plurality of elements that can be extended or retracted (typically through the central member) to change the overall dimensions of the device and ensure that the upper member sits against the dome of the aneurysm and the lower member sits in the neck.
  • the upper and lower members may be attached directly to each other at one or more locations as shown in FIG. 4 or may be attached via the central member or other additional element as shown in FIGS. 1-3 .
  • the upper and lower members may be contiguous, forming a single member as shown in FIG. 5 .
  • the central member may be made of a wide variety of materials and may assume many shapes.
  • the central member may be a tubular or coiled structure, including a lumen therethrough, or may be a wire (e.g., a wire or other structure that serves as both central member and guide/pusher wire).
  • the central member may comprise expandable elements, for example as shown in FIG. 5B .
  • the central member (or an element attached thereto or extending therefrom) is moveable.
  • the central member can have an axially moveable extendable member passing through and extending from the lumen of the central member.
  • the upper member is attached to the extendable member and by extending or retracting the extendable member, the overall dimension of the device can be changed and bolster the upper member.
  • various adjustment means may be used in conjunction with the central member to change the dimensions of the device and thereby transfer force between the upper and lower members including, but not limited to, compressible elements (e.g., elements having characteristics of a spring as depicted in FIG. 1 and FIG. 5A ) and/or an expandable element such as a braid, woven structure or balloon-like structure ( FIG. 5B ).
  • the devices described herein can be made in a wide range of sizes in order to fit any size aneurysm.
  • the operator surgeon will typically image the aneurysm and determine the approximate dimensions, for example from dome to neck.
  • the appropriate size device can then be selected and positioned within the aneurysm as described herein.
  • the device is secured in the desired dimensions by employing one or more locking mechanisms are generally included.
  • a variety of locking mechanisms can be used, as shown in FIGS. 6, 7 and 8 .
  • exemplary locking mechanisms are depicted as positioned on extendable members ( 60 ), which is shown passing through the lumen of central element ( 40 ).
  • the extendable member ( 60 ) shown in the Figures could also be the upper member ( 20 ).
  • FIGS. 6, 7 and 8 are lower member ( 30 ), pusher ( 80 ), detachment junctions ( 25 , 26 ), delivery catheter (or sheath) ( 17 ), and stabilizer catheter (or “pusher tube”) ( 35 ). Delivery catheter ( 17 ) and pusher tube ( 35 ) are coaxial.
  • an expandable material is used to lock the device in the desired dimensions (e.g., maintain the upper and lower members at the desired distance from each other).
  • FIG. 6 panel A, depicts lower member ( 30 ) and extendable member ( 60 ) passing through central member ( 40 ). At the proximal end of extendable member ( 60 ) is detachment junction ( 25 ).
  • Extendable member ( 60 ) further comprises expandable material ( 65 ) that may be expanded upon exposure to one or more selected stimuli.
  • suitable stimuli include exposure to liquid, air (e.g., balloon), change in temperature, electromagnetic radiation and the like.
  • Panel B shows expandable material ( 65 ) in its expanded configuration, which locks the device in the desired overall configuration, both by fitting the expandable material ( 65 ) into the grooves of the lumen of central member ( 40 ) and by providing a stop ( 90 ) that is larger than the lumen of the central member ( 40 ) and does not allow the extendable member ( 60 ) to be moved.
  • FIG. 7 shows an embodiment in which the device is locked into place by interlocking grooves.
  • extendable member ( 60 ) includes grooves ( 65 ) that interlock with the lumen of central member ( 40 ). As long as the extendable member is attached to the pusher ( 80 ), the extendable member ( 60 ) can be moved through the lumen of the central member ( 40 ). Once the desired configuration (distance between upper and lower members) is achieved ( FIG. 6B ), the extendable member ( 60 ) is detached from the pusher ( 80 ) at the detachment junction ( 25 ). Once detached, the overall dimensions of the device remain constant due to the interlocking mechanism.
  • FIG. 8 shows another exemplary locking mechanism that includes an expanding flange-like mechanism ( 95 ).
  • Panel A shows the device as the operator pushes the extendable member ( 60 ) through the central member ( 40 ) in order to place the upper member against the dome of the aneurysm.
  • Panel B shows the device as locked into place with the expandable flange ( 95 ) in its expanded position.
  • the device may also include one or more detachment junctions ( 25 , 26 ), for example so that the upper member can be extended to the proper size for the aneurysm and the portion(s) of the upper member that are not needed detached from the pusher wire and removed from the vessel.
  • the lower member may be detachably joined to a pusher tube ( 35 ).
  • the pusher tube is preferably detached (via detachment junctions ( 26 )) and removed after deployment.
  • Any of the devices described herein may further comprise one or more additional detachment junctions, which is(are) severable by the same or different mechanisms.
  • the detachment junction may be connected to a pusher element, such as a pusher wire or a tubular structure such as a stabilizer catheter (“pusher tube”).
  • the detachment junction can be positioned anywhere on the device, for example at one or both ends of the device.
  • the detachment junction(s) is(are) positioned where the extendable member or upper member is attached to an actuator or locking member.
  • the detachment junction(s) is(are) positioned at the junction between a pusher tube and the lower member or the central member.
  • panels A-D, detachment junction ( 25 ) is positioned the junction of the device and actuator while additional detachment junctions ( 26 ) are positioned at the junctions of the pusher tube ( 35 ) and upper member ( 30 ).
  • the severable junction(s) are, an electrolytically detachable assembly adapted to detach by imposition of a current; a mechanically detachable assembly adapted to detach by movement or pressure; a thermally detachable assembly adapted to detach by localized delivery of heat to the junction; a radiation detachable assembly adapted to detach by delivery of electromagnetic radiation to the junction or combinations thereof.
  • one or more actuators may be included so that an operator can manipulate the shape or position of the device.
  • the moveable members may be attached, either directly or through another element such as a pusher wire, to an actuator.
  • the pusher wire both advances the device into the aneurysm and acts as the actuator to adjust the overall dimensions.
  • a pusher wire can serve as guide wire and, optionally actuator.
  • the extendable element ( 60 ) of FIG. 2 can be the pusher wire that is attached to the upper member ( 20 ) and extendable through the central member ( 40 ).
  • the pusher wire can be attached to the central member to actuate expansion of one or more components. ( FIG. 5B ).
  • actuators may include one or more handles, dials or the like with which the operator (e.g., surgeon placing the device) controls movement of the device, adjusts the dimensions (e.g., by changing the distance between the upper and lower members and/or expanding a balloon or basket shaped structure) once in the aneurysm and/or locks the device into a desired configuration.
  • the devices described herein may also comprise additional components, such as co-solvents, plasticizers, coalescing solvents, bioactive agents, antimicrobial agents, antithrombogenic agents, antibiotics, pigments, radiopacifiers and/or ion conductors which may be coated using any suitable method or may be incorporated into the element(s) during production. See, e.g., co-owned U.S. patent application Ser. No. 10/745,911, U.S. Pat. No. 6,585,754 and WO 02/051460, incorporated by reference in their entireties herein.
  • the location of the device is preferably visible using fluoroscopy.
  • a highly preferred method is to ensure that at least some of the elements making up the device are provided with significant radio-visibility via the placement of a radio-opaque covering on these elements.
  • a metallic coating of a metal having comparatively more visibility, during fluoroscopic use, than stainless steel is preferred.
  • Such metals are well known but include gold and members of the Platinum Group described above.
  • one of more of the elements may also be secured to each other at one or more locations.
  • various elements may be thermoplastic, they may be melted or fused to other elements of the devices. Alternatively, they may be glued or otherwise fastened.
  • the various elements may be secured to each other in one or more locations.
  • the devices described herein are often introduced into a selected site using the procedure outlined below. This procedure may be used in treating a variety of maladies. For instance in the treatment of an aneurysm, the aneurysm itself will be filled (partially or fully) with the devices described herein.
  • devices as described above are delivered to an aneurysm via a delivery catheter. It will be apparent that the device is preferably delivered in an undeployed shape, e.g., a tubular shape and that, following deployment, the device assumes a different three-dimensional configuration.
  • the device may be self-configuring (e.g., self-expanding) upon deployment, may require actuation by one or more stimuli and/or may be partially self-configuring and partially shaped by application of one or more stimuli.
  • Self-configuring materials include shape memory alloys and polymers, described above. Thus, the super-elastic characteristics of these materials allow the device to be deployed in a compressed configuration and upon deployment, to assume its three-dimensional configuration. It is to be understood that the three-dimensional configuration assumed by self-configuring devices may also be shaped further (e.g., changing the distance between lower and upper members) using one or more stimuli described below.
  • the device assumes a deployed configuration upon the application of one or more appropriate stimuli.
  • the device may be configured so as to achieve its deployed shape when exposed to body temperature (e.g., temperature of the aneurysm).
  • body temperature e.g., temperature of the aneurysm
  • the martensite temperature is adjusted to be at a lower temperature. With these temperatures set, the device is heated to, or above the training temperature (austentite phase) and shaped into its desired deployed shape, as described above. Then, the temperature is lowered to, or below, the martensite finish temperature and shaped into its desired undeployed shape.
  • the catheter can be constructed of a material that insulates the device from the outside environment and maintains the temperature of the device below the activation temperature. Thus, when the catheter is inserted into the lumen of the blood vessel, the device does not expand into its deployed shape within the catheter.
  • the device self-expands and, subsequently, one or more stimuli are also applied to achieve the desired configuration and/or to lock the device in the desired configuration.
  • the mechanism will be such as to be capable of being advanced entirely through the catheter to place vaso-occlusive device at the target site but yet with a sufficient portion of the distal end of the delivery mechanism protruding from the distal end of the catheter to enable detachment of the implantable vaso-occlusive device.
  • the device e.g., lower member
  • the device is attached to the distal end of a retractable sheath (also referred to as a pusher tube).
  • the device may be extended and retracted from the pusher tube (by the actuator) and delivery catheter until the desired configuration is achieved, at which point, the pusher tube is detached from the device and withdrawn along with the delivery catheter.
  • the delivery mechanism will normally be about 100-200 cm in length, more normally 130-180 cm in length.
  • the diameter of the delivery mechanism is usually in the range of 0.25 to about 2.0 mm.
  • occlusive devices (and/or additional components) described herein are typically loaded into a carrier for introduction into a delivery catheter and introduced to the chosen site using the procedure outlined below. This procedure may be used in treating a variety of maladies. For instance, in treatment of an aneurysm, the aneurysm itself may be filled with a device as described herein which cause formation of an emboli and, at some later time, is at least partially replaced by neovascularized collagenous material formed around the implanted vaso-occlusive devices.
  • a selected site is reached through the vascular system using a collection of specifically chosen catheters and/or guide wires. It is clear that should the site be in a remote site, e.g., in the brain, methods of reaching this site are somewhat limited.
  • One widely accepted procedure is found in U.S. Pat. No. 4,994,069 to Ritchart, et al. It utilizes a fine endovascular catheter such as is found in U.S. Pat. No. 4,739,768, to Engelson.
  • a large catheter is introduced through an entry site in the vasculature. Typically, this would be through a femoral artery in the groin.
  • Other entry sites sometimes chosen are found in the neck and are in general well known by physicians who practice this type of medicine.
  • a guiding catheter is then used to provide a safe passageway from the entry site to a region near the site to be treated.
  • a guiding catheter would be chosen which would extend from the entry site at the femoral artery, up through the large arteries extending to the heart, around the heart through the aortic arch, and downstream through one of the arteries extending from the upper side of the aorta.
  • a guidewire and neurovascular catheter such as that described in the Engelson patent are then placed through the guiding catheter. Once the distal end of the catheter is positioned at the site, often by locating its distal end through the use of radiopaque marker material and fluoroscopy, the catheter is cleared. For instance, if a guidewire has been used to position the catheter, it is withdrawn from the catheter and then the assembly, for example including the vaso-occlusive device at the distal end, is advanced through the catheter.
  • the delivery catheter comprises a retractable sheath (or pusher tube) at its distal end that surrounds the device to be delivered.
  • the retractable distal sheath includes a pull back means operatively connected to the distal sheath.
  • the catheter may be constructed and arranged such that distal end of the sheath does not extend past the distal end catheter.
  • the distal end of the sheath may extend beyond the distal end of the delivery catheter, for example so that is extrudes the device directly into the target site.
  • the devices described herein are detachably linked to the distal end of a retractable sheath.
  • FIGS. 6-9 Non-limiting examples of suitable delivery catheters will be known to those of skill in the art in view of the teachings herein. See, also, U.S. Pat. Nos. 6,425,914; 5,772,669; and 6,391,050.
  • the vaso-occlusive device is extruded, for example by retracting the sheath surrounding and mounted to the device.
  • the vaso-occlusive device is loaded onto the pusher wire and/or tube via a mechanically or electrolytically cleavable junction (e.g., a GDC-type junction that can be severed by application of heat, electrolysis, electrodynamic activation or other means).
  • a mechanically or electrolytically cleavable junction e.g., a GDC-type junction that can be severed by application of heat, electrolysis, electrodynamic activation or other means.
  • the vaso-occlusive device can be designed to include multiple detachment points, as described in co-owned U.S. Pat. No. 6,623,493 and 6,533,801 and International Patent publication WO 02/45596. Once detached the devices are held in place by gravity, shape, size, volume, magnetic field or combinations thereof.
  • the device After deployment and prior to detachment from the pusher wire and/or pusher tube, it may be preferable to lock the device in the desired configuration. This can be accomplished in any number of ways, for example, using locking elements as shown in FIGS. 6-8 . As can be seen in the exemplary embodiments depicted in these Figures, the inclusion of one or more locking mechanisms helps ensure the overall configuration of the device and, accordingly, the efficient transfer of force between the upper and lower members and the surfaces of the aneurysm they contact. Detachment from the pusher wire and/or pusher tube can then be accomplished as described above.
  • FIG. 9A shows a side-view of the lower and central members of an exemplary device as described herein as it is advanced through the delivery catheter ( 17 ) by the pusher wire ( 80 ).
  • Lower member ( 30 ) is constrained in linear position by delivery catheter ( 17 ) and by pusher catheter sheath ( 35 ).
  • Extendable member ( 60 ) further comprises an expandable member ( 65 ).
  • Central member ( 40 ) is depicted with inward-facing grooves.
  • FIG. 9B depicts how lower member ( 30 ) assumes an expanded, three-dimensional configuration upon extrusion from pusher catheter sheath ( 35 ) and delivery catheter ( 17 ).
  • FIG. 9A shows a side-view of the lower and central members of an exemplary device as described herein as it is advanced through the delivery catheter ( 17 ) by the pusher wire ( 80 ).
  • Lower member ( 30 ) is constrained in linear position by delivery catheter ( 17 ) and by pusher catheter sheath ( 35 ).
  • FIG. 9C depicts the device in a locked position after expansion of expandable member ( 65 ).
  • pusher wire is shown as detached from extendable member ( 60 ) via detachment junction ( 25 ).
  • FIG. 9D shows the withdrawal of the delivery catheter ( 17 ) and pusher catheter ( 35 ), leaving the device in place where desired.
  • Pusher catheter ( 35 ) is detached from lower member ( 30 ) via detachment junctions ( 26 ).

Abstract

Devices for occluding an aneurysm are provided. In particular, the device include an upper member that sits against the dome of the aneurysm, a lower member that sits in the neck of the aneurysm, and a means of adjusting the overall dimensions of the device. Also provided are methods of making and using these devices.

Description

    FIELD OF THE INVENTION
  • Compositions and methods for repair and treatment of aneurysms are described. In particular, devices and systems for placement in an aneurysm are disclosed, as are methods of making and using these devices.
  • BACKGROUND
  • An aneurysm is a dilation of a blood vessel that poses a risk to health from the potential for rupture, clotting, or dissecting. Rupture of an aneurysm in the brain causes stroke, and rupture of an aneurysm in the abdomen causes shock. Cerebral aneurysms are usually detected in patients as the result of a seizure or hemorrhage and can result in significant morbidity or mortality.
  • There are a variety of materials and devices which have been used for treatment of aneurysms, including platinum and stainless steel microcoils, polyvinyl alcohol sponges (Ivalone), and other mechanical devices. For example, vaso-occlusion devices are surgical implements or implants that are placed within the vasculature of the human body, typically via a catheter, either to block the flow of blood through a vessel making up that portion of the vasculature through the formation of an embolus or to form such an embolus within an aneurysm stemming from the vessel. One widely used vaso-occlusive device is a helical wire coil having windings that may be dimensioned to engage the walls of the vessels. (See, e.g., U.S. Pat. No. 4,994,069 to Ritchart et al.). Other less stiff helically coiled devices have been described, as well as those involving woven braids. See, e.g., U.S. Pat. No. 6,299,627.
  • U.S. Pat. No. 5,354,295 and its parent, U.S. Pat. No. 5,122,136, both to Guglielmi et al., describe an electrolytically detachable embolic device. Vaso-occlusive coils having little or no inherent secondary shape have also been described. For instance, co-owned U.S. Pat. Nos. 5,690,666; 5,826,587; and 6,458,119 by Berenstein et al., describes coils having little or no shape after introduction into the vascular space. U.S. Pat. No. 5,382,259 describes non-expanding braids covering a primary coil structure.
  • However, there is a risk that known coil designs will migrate fully or partially out of the aneurysm entrance zone and into the feeding vessel. This risk is particularly high with wide neck aneurysms. Generally, wide neck aneurysms are those in which the neck (the entrance zone) has a diameter that either: (1) is at least 80% of the largest diameter of the aneurysm; or (2) is clinically observed to be too wide effectively to retain vaso-occlusive coils that are deployed using the techniques discussed above. Accordingly, devices for retaining coils within aneurysms have been described. See, e.g., U.S. Pat. No. 6,168,622 and U.S. Patent Application Publication No. 20030195553.
  • Thus, there remains a need for systems and methods for occluding an aneurysm neck would be desirable, including systems that do not rely on coils that may migrate out of aneurysms.
  • SUMMARY OF THE INVENTION
  • Thus, this invention includes novel occlusive devices as well as methods of using and making these devices.
  • In one aspect, the invention includes a vaso-occlusive device for placement within an aneurysm having a neck and a dome, the device comprising a lower member having a linear configuration prior to deployment and a deployed open configuration, wherein the deployed configuration bridges the neck of the aneurysm; an upper member having a undeployed, linear configuration prior and an open, deployed configuration, wherein the deployed configuration rests against at least a portion of the dome of the aneurysm, and a means of adjusting the overall dimensions of the device. In certain embodiments, the distance between the upper and lower members is adjustable. In other embodiments, the lower and/or upper member is compressible (e.g., deformable against the wall of the aneurysm).
  • In any of the devices described herein, the upper and lower members may be contiguous or alternatively, the upper and lower members may be separate, for example when the device further comprises an adjustable central member having a proximal end connected to the lower member and distal end connected to the upper member. One or more of the upper member lower member and optional central member may be compressible or may comprise a compressible element. Furthermore, the optional central member may further comprise an extendable member connected to the upper member; and/or an expandable element.
  • In any of the devices described herein, the upper member may comprise a plurality of axially moveable wires passing through the lumen of the central member, each wire comprising a distal end and a proximal end. In certain embodiments, the distal end of one or more of the wires is attached to the central member and/or to the lower member. The upper member may be compressible or deformable, for example against the dome of an aneurysm, thereby changing the overall dimensions of the device.
  • In another aspect, the invention includes any of the devices as described herein, which device further comprises one or more detachment junctions, each detachment junction comprising an electrolytically detachable end adapted to detach by imposition of a current thereon. One or more detachment junctions may be positioned between the upper member and a pusher wire and/or between the lower member and a pusher tube.
  • In another aspect, the invention includes any of the devices as described herein, which device further comprises one or more locking mechanisms. In certain embodiments, the locking mechanism comprises an expandable material, for example a self-expanding element.
  • In yet another aspect, the invention includes any of the devices as described herein, wherein the upper member comprises a metal, for example, a metal selected from the group consisting of nickel, titanium, platinum, gold, tungsten, iridium and alloys or combinations thereof. In certain embodiments, the upper member comprises the alloy nitinol.
  • In yet another aspect, the invention includes any of the devices as described herein, wherein the lower member comprises a metal, for example a metal selected from the group consisting of platinum, palladium, rhodium, gold, tungsten and alloys thereof. In certain embodiment, the lower member comprises nitinol.
  • In yet another aspect, the invention includes any of the devices as described herein, wherein the upper and/or lower member comprises a braid or mesh configuration. In certain embodiments, the lower member comprises a mesh or braid structure. In other embodiments, the lower member comprises a film (e.g., a porous film, a polymer film or a metallic film).
  • In a still further aspect, the invention includes any of the devices as described herein, which device further comprises an additional component, for example a bioactive component.
  • In yet another aspect, the invention includes a method of occluding a body cavity comprising introducing a vaso-occlusive device as described herein into the body cavity (e.g., an aneurysm). These and other embodiments of the subject invention will readily occur to those of skill in the art in light of the disclosure herein.
  • BRIEF DESCRIPTION OF THE FIGURES
  • In order to better appreciate how the devices, methods and other advantages and objects of the present disclosure, a more particular description will be rendered by reference to specific embodiments thereof, which are illustrated in the accompanying drawings. It is to be understood that the drawings depict only exemplary embodiments and are not to be considered limiting in scope.
  • FIG. 1 depicts a side-view of an exemplary assembly as described herein having umbrella shaped upper and lower members. A compressible, spring-like central member connects the upper and lower members and adjusts the distance between the upper and lower members.
  • FIG. 2 depicts a side-view of an exemplary assembly as described herein having umbrella shaped upper and lower members. The distance between the upper and lower member can be adjusted by extending or retracting an extendable member located on a central member. The central member connects and extends between the upper and lower members.
  • FIG. 3 depicts a side view of another exemplary assembly as described herein having an umbrella shaped lower member from which a central tubular member extends. The central member may be integral to or separate from the lower member. Upper member comprises a plurality of individual members that extend from and loop back into the central member. Upper member elements are extendable and retractable through the central member.
  • FIG. 4 depicts a side view of another exemplary assembly as described herein having an umbrella shaped lower member from which a central tubular member extends. The central member may be integral to or separate from the lower member. Upper member comprises a plurality of individual members that extend from and the central member. Upper member elements are attached at their distal ends to the lower member and may be extended or retracted through the central member to change the overall dimensions of the device.
  • FIG. 5, panels A and B, are side views depicting another exemplary embodiment in which the upper and lower members comprise a contiguous element. Panel A depicts contiguous upper and lower members connected by a central member that includes a compressible member. Panel B depicts contiguous upper and lower members that are expandable and an expandable central member.
  • FIG. 6, panels A and B, are side views of an exemplary locking mechanism. Panel A depicts the device in an unlocked position in which the distance between upper and lower members can be adjusted. Panel B depicts the locked position in which the distance between the upper and lower members remains fixed. Also shown is detachment junction for releasing the device once the desired configuration is achieved.
  • FIG. 7, panels A and B, are side views of an exemplary locking mechanism. Panel A depicts the device in an unlocked position in which the distance between upper and lower members can be adjusted. Panel B depicts the locked position in which the distance between the upper and lower members remains fixed. Also shown is detachment junction for releasing the device once the desired configuration is achieved.
  • FIG. 8, panels A and B, are side views of an exemplary locking mechanism. Panel A depicts the device in an unlocked position in which the distance between upper and lower members can be adjusted. Panel B depicts the locked position in which the distance between the upper and lower members remains fixed. Also shown is detachment junction for releasing the device once the desired configuration is achieved.
  • FIG. 9, panels A to D, depict exemplary deployment procedure. Panel A depicts the lower portion of the device as it is advanced through the delivery catheter by the pusher wire. Panel B shows expansion of the lower member after extrusion from a constraining member (e.g., pusher catheter and/or sheath). Panel C shows the device after it is locked in place via an expandable material and after the pusher wire has been detached. Panel D shows detachment of the pusher catheter and removal of the pusher and delivery catheters. Although all panels show partial side-views depicting lower and central members, it will be appreciated that the devices shown will also include upper members as described herein.
  • DESCRIPTION OF THE INVENTION
  • Occlusive (e.g., embolic) devices are described. The devices described herein find use in vascular and neurovascular indications and are particularly useful in treating aneurysms, for example wide-neck, small-diameter, curved or otherwise difficult to access vasculature, for example aneurysms, such as cerebral aneurysms. Methods of making and using these vaso-occlusive devices also form aspects of this invention.
  • All publications, patents and patent applications cited herein, whether above or below, are hereby incorporated by reference in their entirety.
  • It must be noted that, as used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural references unless the content clearly dictates otherwise. Thus, for example, reference to a device comprising “an extendable member” includes devices comprising of two or more elements.
  • The device is a surgical implement and can be readily deployed, removed and/or repositioned in human vasculature. Typically, the devices include a lower member, an upper member and a means for adjusting the overall dimensions of the device, including, for example, a means of adjusting the distance between the lower and upper members. The upper and lower members may be separate or contiguous elements. In addition, one or both of the upper and lower members may be compressible. The lower member typically sits in the neck of the aneurysm while the upper member sits against the walls (e.g., dome) of the aneurysm.
  • Overall dimensions of the device are changed using any suitable adjustment means. For example, in certain embodiments, the upper and/or lower member may be moved in relation to each other (e.g., extended, expanded, compressed, etc.) in order to change the overall dimensions of the device. One or more adjustable elements (e.g., a central member) may be employed to facilitate the change the dimensions, for example an extendable central member connecting the lower and upper members may be included.
  • Depicted in the Figures are exemplary embodiments of the present invention. It will be appreciated that this is for purposes of illustration only and that the various elements depicted can be of other materials or shapes.
  • Turning to FIG. 1, device (10) constructed in accordance with one embodiment of the present invention is shown in a side-view of a deployed position within an aneurysm (70) of a blood vessel (15). The aneurysm (70) is shown with an oppositely disposed neck (75) and dome (85). As shown in the FIG. 1, upper (20) and lower (30) members have a flared open (umbrella) configuration after deployment that advantageously conforms to the shape of the aneurysm (70). The diameter of the upper member (20) is larger than the neck (75), and thus preferably completely covers the neck (75) upon deployment. Also shown in FIG. 1 is central member (40), which is connected at its distal end to upper member (20) and at its proximal end to lower member (30). Central member (40) also includes a compressible portion (50) that acts as a spring to adjust the distance between and to transfer force from lower member (30) to upper member (20). Central member (40) may also be extendable.
  • FIG. 2 shows a side view of another variation in which the distance between upper (20) and lower (30) members can be adjusted using an extendable member (60) extending from the distal end of central member (40). Extendable member (60) can be extended and retracted from the lumen of the central member (40) to move the upper (20) and lower (30) members closer together or farther apart. In this variation, the upper member (20) is attached to the distal end of the extendable member (60) and the lower member (30) is attached to the distal end of the tubular central member (40). As will be described further herein, movement of the extendable member (60) can be controlled by any suitable actuator.
  • FIG. 3 shows a side view of another variation in which the overall dimensions are adjusted using an extendable upper member (20). Upper member (20) comprises a plurality of moveable elements (e.g., wires or microcoils) that extend from an optional central member (40). In this variation, the plurality of extendable members that comprise upper member (20) form loops as they extend from and back into a lumen in the central member (40). The distal ends of the wires are shown attached to the central member (40) while the proximal ends can be extended or retracted by an operator until the device has the desired overall dimensions (e.g., the loop portion abuts the dome of the aneurysm). In certain embodiments, the wires making up the loops of the upper member may be compressed against the upper wall of the aneurysm upon deployment and thereby change the distance between the uppermost portion of the device and the lower member.
  • FIG. 4 depicts a side view of a variation similar to that shown in FIG. 3 in which the distal ends of the plurality of moveable upper member elements (20) are attached to the lower member (30) rather than the central member (40). As with the embodiment shown in FIG. 3, the proximal ends can be extended or retracted by an operator, thereby forcing the loop portion against the dome of the aneurysm. Also as shown in FIG. 3, the wires may be compressed against the upper wall of the aneurysm upon deployment, thereby changing the overall configuration of the device.
  • FIG. 5, panels A and B, depict another variation in which the upper member (20) and lower member (30) are a single structure. Panel A is a side view of an exemplary embodiment in which upper (20) and lower (30) members are connected by central member (40). Central member further comprises a compressible portion (50) to adjust distance between upper and lower members. Panel B is a side view of an exemplary embodiment in which upper (20) and lower (30) members comprise a plurality of wires that can expand the overall diameter of the device. Central member (40) also comprises an expandable member (55).
  • In embodiments in which the upper and lower members are contiguous, the contiguous structure may take any number of forms, including but not limited to, wires (FIG. SB), braided or woven configurations, solid configurations (FIG. 5A) and the like. It will be apparent that, as a whole, the materials making up contiguous upper and lower member structures may vary in different portions of the structure. For example, in braided or woven structures, the tightness of the braid or weave may be different in the upper portion as compared to the lower portion. Similarly, different additional components may be used in different portions of a contiguous upper and lower member structure.
  • As shown in the Figures, the overall dimensions of the devices described herein are adjustable, thereby facilitating a transfer of force between the lower member (in the neck) to the upper member (the dome of the aneurysm). The dimensions can be adjusted (and force transferred) in a variety of ways, including but not limited to, the inclusion a moveable central member; a moveable upper member; springs; and/or expandable elements such as balloons. Whatever force transfers design or combinations of designs are employed, the adjustable nature of the dimension(s) of the devices described herein aid in ensuring that the lower member sits in the neck the aneurysm while the upper member presses safely against the dome of the aneurysm. Preferably, the area of contact between the upper and the aneurysm wall is maximized so as to distribute the force across the widest possible area and thus exert the least amount of pressure on the aneurysm wall. Furthermore, it is to be understood that one or more design features shown in the Figures and described herein can be combined into one device.
  • Although the devices described herein are capable of retaining finer vaso-occlusive devices (e.g., coils, liquid embolics, etc.) within the aneurysm, they are also capable of functioning as vaso-occlusive devices by themselves. As can be appreciated by one of ordinary skill in the art, the force-transfer effect achieved by including one or more adjustment means (e.g., moveable elements) serves to anchor the device in the aneurysm and reinforce the lower member so that it is able to remain stably situated across the aneurysm neck while diverting the flow of blood from within the aneurysm.
  • As will be apparent, the devices described herein may conform to a range of shapes and sizes of aneurysms since the dimensions are adjustable. Furthermore, following the teachings described herein, the devices can be sized to fit aneurysms ranging in size from millimeters in diameter to centimeters in diameter. In this way, the operator can select a device of a generally suitable size for the particular indication and adjust it to fit securely by conforming the upper member to the dome of the aneurysm.
  • As noted above, the lower member and upper members may assume a variety of structures, for example, umbrella, dome, balloon, teardrop or cone shape. The deployed configuration of the lower member is preferably such that it sits in and covers the neck of the aneurysm. Similarly, the deployed configuration of the upper member is such that it sits safely against the dome of the aneurysm (e.g., back inner wall). Generally, the overall structure of the upper member is typically more variable than that of the lower member and includes, but is not limited to, configuration such as umbrella shapes, strings or wires formed into loops, etc. One or both of the lower and upper members may also include thin-film, braided, mesh like or basket type structures. Furthermore, the upper and lower members may be a single element, for example expandable structures, for example as shown in FIG. 5.
  • Upper and lower members can be constructed from a wide variety of materials, including, but not limited to, metals, metal alloys, polymers or combinations thereof. See, e.g., U.S. Pat. Nos. 6,585,754 and 6,280,457 for a description of various polymers. Non-limiting examples of suitable metals include, Platinum Group metals, especially platinum, rhodium, palladium, rhenium, as well as tungsten, gold, silver, tantalum, stainless steel and alloys of these metals. Preferably, the lower member comprises a material that maintains its shape despite being subjected to high stress, for example, “super-elastic alloys” such as nickel/titanium alloys (48-58 atomic % nickel and optionally containing modest amounts of iron); copper/zinc alloys (38-42 weight % zinc); copper/zinc alloys containing 1-10 weight % of beryllium, silicon, tin, aluminum, or gallium; or nickel/aluminum alloys (36-38 atomic % aluminum). Particularly preferred are the alloys described in U.S. Pat. Nos. 3,174,851; 3,351,463; and 3,753,700. Especially preferred is the titanium/nickel alloy known as “nitinol.”
  • Shape memory alloys comprise a unique class of metal alloys that, once trained, are configured to “remember” a pre-selected shape, i.e., deployed shape, and can return to the pre-selected shape even if subsequently reshaped. To be trained to “remember” a first pre-selected shape, the shape memory alloy is molded and heated at or above a training, or austenite, temperature to place the shape memory alloy in an austenite phase. In the austenite phase, the shape memory alloy is formed in the first pre-selected shape and then, once formed, is permitted to cool to a martensite finish temperature, whereupon the shape memory alloy enters a martensite phase. The martensite finish temperature can be any temperature that is less than the training temperature. Upon entering the martensite phase, the shape memory alloy has been trained to “remember” the first pre-selected shape. While in the martensite phase, the alloy is in a soft state and is formed into a second pre-selected shape, e.g., an undeployed shape. The shape memory alloy in the martensite phase is configured to maintain the second pre-selected shape and, if subsequently reheated to an activation temperature, automatically returns to the first pre-selected shape. The activation temperature can comprise any temperature that is greater than the martensite finish temperature and generally approximately equals the training temperature. Once the first pre-selected shape has been recovered, the shape memory alloy is configured to maintain the first pre-selected shape irrespective of temperature. Generally, as can be appreciated by one of ordinary skill in the art, the training, martensite finishing, and activation temperatures for a shape memory alloy are adjustable, depending on the composition. For example, a slight extra amount of Nickel added to a NiTi alloy composition can change the training temperature from approximately 0° C. to 100° C. The lower member may also comprise a shape memory polymer such as those described in International Publication WO 03/51444.
  • In certain embodiments, the upper and/or lower members of the devices described herein may also be moveable. For instance, as shown in FIG. 3 and FIG. 4, the upper member may comprise a plurality of elements that can be extended or retracted (typically through the central member) to change the overall dimensions of the device and ensure that the upper member sits against the dome of the aneurysm and the lower member sits in the neck.
  • As noted above, the upper and lower members may be attached directly to each other at one or more locations as shown in FIG. 4 or may be attached via the central member or other additional element as shown in FIGS. 1-3. Alternatively, the upper and lower members may be contiguous, forming a single member as shown in FIG. 5.
  • When present, the central member may be made of a wide variety of materials and may assume many shapes. The central member may be a tubular or coiled structure, including a lumen therethrough, or may be a wire (e.g., a wire or other structure that serves as both central member and guide/pusher wire). The central member may comprise expandable elements, for example as shown in FIG. 5B.
  • In certain embodiments, the central member (or an element attached thereto or extending therefrom) is moveable. For instance, as shown in FIG. 2, the central member can have an axially moveable extendable member passing through and extending from the lumen of the central member. The upper member is attached to the extendable member and by extending or retracting the extendable member, the overall dimension of the device can be changed and bolster the upper member. As noted above, various adjustment means may be used in conjunction with the central member to change the dimensions of the device and thereby transfer force between the upper and lower members including, but not limited to, compressible elements (e.g., elements having characteristics of a spring as depicted in FIG. 1 and FIG. 5A) and/or an expandable element such as a braid, woven structure or balloon-like structure (FIG. 5B).
  • It will be apparent that the devices described herein can be made in a wide range of sizes in order to fit any size aneurysm. As described above, the operator (surgeon) will typically image the aneurysm and determine the approximate dimensions, for example from dome to neck. The appropriate size device can then be selected and positioned within the aneurysm as described herein.
  • In certain embodiments, the device is secured in the desired dimensions by employing one or more locking mechanisms are generally included. A variety of locking mechanisms can be used, as shown in FIGS. 6, 7 and 8. For convenience, exemplary locking mechanisms are depicted as positioned on extendable members (60), which is shown passing through the lumen of central element (40). However, it will be apparent that the extendable member (60) shown in the Figures could also be the upper member (20). Also shown in FIGS. 6, 7 and 8 are lower member (30), pusher (80), detachment junctions (25, 26), delivery catheter (or sheath) (17), and stabilizer catheter (or “pusher tube”) (35). Delivery catheter (17) and pusher tube (35) are coaxial.
  • In the variation shown in FIG. 6, an expandable material is used to lock the device in the desired dimensions (e.g., maintain the upper and lower members at the desired distance from each other). FIG. 6, panel A, depicts lower member (30) and extendable member (60) passing through central member (40). At the proximal end of extendable member (60) is detachment junction (25). Extendable member (60) further comprises expandable material (65) that may be expanded upon exposure to one or more selected stimuli. Non-limiting examples of suitable stimuli include exposure to liquid, air (e.g., balloon), change in temperature, electromagnetic radiation and the like. Panel B shows expandable material (65) in its expanded configuration, which locks the device in the desired overall configuration, both by fitting the expandable material (65) into the grooves of the lumen of central member (40) and by providing a stop (90) that is larger than the lumen of the central member (40) and does not allow the extendable member (60) to be moved.
  • FIG. 7 shows an embodiment in which the device is locked into place by interlocking grooves. In particular, extendable member (60) includes grooves (65) that interlock with the lumen of central member (40). As long as the extendable member is attached to the pusher (80), the extendable member (60) can be moved through the lumen of the central member (40). Once the desired configuration (distance between upper and lower members) is achieved (FIG. 6B), the extendable member (60) is detached from the pusher (80) at the detachment junction (25). Once detached, the overall dimensions of the device remain constant due to the interlocking mechanism.
  • FIG. 8 shows another exemplary locking mechanism that includes an expanding flange-like mechanism (95). Panel A, shows the device as the operator pushes the extendable member (60) through the central member (40) in order to place the upper member against the dome of the aneurysm. Panel B shows the device as locked into place with the expandable flange (95) in its expanded position.
  • Also as shown in FIGS. 6-9, the device may also include one or more detachment junctions (25, 26), for example so that the upper member can be extended to the proper size for the aneurysm and the portion(s) of the upper member that are not needed detached from the pusher wire and removed from the vessel. In certain embodiments, the lower member may be detachably joined to a pusher tube (35). The pusher tube is preferably detached (via detachment junctions (26)) and removed after deployment. Any of the devices described herein may further comprise one or more additional detachment junctions, which is(are) severable by the same or different mechanisms. The detachment junction may be connected to a pusher element, such as a pusher wire or a tubular structure such as a stabilizer catheter (“pusher tube”).
  • The detachment junction can be positioned anywhere on the device, for example at one or both ends of the device. In certain embodiments, the detachment junction(s) is(are) positioned where the extendable member or upper member is attached to an actuator or locking member. In other embodiments, the detachment junction(s) is(are) positioned at the junction between a pusher tube and the lower member or the central member. In still other embodiments, for example as shown in FIG. 9, panels A-D, detachment junction (25) is positioned the junction of the device and actuator while additional detachment junctions (26) are positioned at the junctions of the pusher tube (35) and upper member (30).
  • In certain embodiments, the severable junction(s) are, an electrolytically detachable assembly adapted to detach by imposition of a current; a mechanically detachable assembly adapted to detach by movement or pressure; a thermally detachable assembly adapted to detach by localized delivery of heat to the junction; a radiation detachable assembly adapted to detach by delivery of electromagnetic radiation to the junction or combinations thereof.
  • Furthermore, one or more actuators may be included so that an operator can manipulate the shape or position of the device. For example, the moveable members may be attached, either directly or through another element such as a pusher wire, to an actuator. In certain embodiments, the pusher wire both advances the device into the aneurysm and acts as the actuator to adjust the overall dimensions. As noted above, a pusher wire can serve as guide wire and, optionally actuator. For example, the extendable element (60) of FIG. 2 can be the pusher wire that is attached to the upper member (20) and extendable through the central member (40). Similarly, the pusher wire can be attached to the central member to actuate expansion of one or more components. (FIG. 5B). FIGS. 6-9 show pusher wire (80) that also actuates movement of the device. Additionally, actuators may include one or more handles, dials or the like with which the operator (e.g., surgeon placing the device) controls movement of the device, adjusts the dimensions (e.g., by changing the distance between the upper and lower members and/or expanding a balloon or basket shaped structure) once in the aneurysm and/or locks the device into a desired configuration.
  • The devices described herein may also comprise additional components, such as co-solvents, plasticizers, coalescing solvents, bioactive agents, antimicrobial agents, antithrombogenic agents, antibiotics, pigments, radiopacifiers and/or ion conductors which may be coated using any suitable method or may be incorporated into the element(s) during production. See, e.g., co-owned U.S. patent application Ser. No. 10/745,911, U.S. Pat. No. 6,585,754 and WO 02/051460, incorporated by reference in their entireties herein.
  • As noted elsewhere, the location of the device is preferably visible using fluoroscopy. A highly preferred method is to ensure that at least some of the elements making up the device are provided with significant radio-visibility via the placement of a radio-opaque covering on these elements. A metallic coating of a metal having comparatively more visibility, during fluoroscopic use, than stainless steel is preferred. Such metals are well known but include gold and members of the Platinum Group described above.
  • As noted above, one of more of the elements may also be secured to each other at one or more locations. For example, to the extent that various elements are thermoplastic, they may be melted or fused to other elements of the devices. Alternatively, they may be glued or otherwise fastened. Furthermore, the various elements may be secured to each other in one or more locations.
  • Methods of Use
  • The devices described herein are often introduced into a selected site using the procedure outlined below. This procedure may be used in treating a variety of maladies. For instance in the treatment of an aneurysm, the aneurysm itself will be filled (partially or fully) with the devices described herein.
  • Generally, devices as described above are delivered to an aneurysm via a delivery catheter. It will be apparent that the device is preferably delivered in an undeployed shape, e.g., a tubular shape and that, following deployment, the device assumes a different three-dimensional configuration. The device may be self-configuring (e.g., self-expanding) upon deployment, may require actuation by one or more stimuli and/or may be partially self-configuring and partially shaped by application of one or more stimuli.
  • Self-configuring materials include shape memory alloys and polymers, described above. Thus, the super-elastic characteristics of these materials allow the device to be deployed in a compressed configuration and upon deployment, to assume its three-dimensional configuration. It is to be understood that the three-dimensional configuration assumed by self-configuring devices may also be shaped further (e.g., changing the distance between lower and upper members) using one or more stimuli described below.
  • In other embodiments, the device assumes a deployed configuration upon the application of one or more appropriate stimuli. For example, the device may be configured so as to achieve its deployed shape when exposed to body temperature (e.g., temperature of the aneurysm). This can be readily achieved by adjusting the training and activation temperatures to be at, or just below, the temperature of the aneurysm (e.g., approximately 37° C.). The martensite temperature is adjusted to be at a lower temperature. With these temperatures set, the device is heated to, or above the training temperature (austentite phase) and shaped into its desired deployed shape, as described above. Then, the temperature is lowered to, or below, the martensite finish temperature and shaped into its desired undeployed shape. Subsequently, the device is then placed inside the catheter for delivery. The catheter can be constructed of a material that insulates the device from the outside environment and maintains the temperature of the device below the activation temperature. Thus, when the catheter is inserted into the lumen of the blood vessel, the device does not expand into its deployed shape within the catheter.
  • Other stimuli that can be used to change the configuration of the device upon deployment include application of electromagnetic radiation (light), electricity, mechanical pressure, etc. In certain embodiments, the device self-expands and, subsequently, one or more stimuli are also applied to achieve the desired configuration and/or to lock the device in the desired configuration.
  • Conventional catheter insertion and navigational techniques involving guidewires or flow-directed devices may be used to access the site with a catheter. The mechanism will be such as to be capable of being advanced entirely through the catheter to place vaso-occlusive device at the target site but yet with a sufficient portion of the distal end of the delivery mechanism protruding from the distal end of the catheter to enable detachment of the implantable vaso-occlusive device. In certain embodiments, the device (e.g., lower member) is attached to the distal end of a retractable sheath (also referred to as a pusher tube). The device may be extended and retracted from the pusher tube (by the actuator) and delivery catheter until the desired configuration is achieved, at which point, the pusher tube is detached from the device and withdrawn along with the delivery catheter. FIG. 9.
  • For use in peripheral or neural surgeries, the delivery mechanism will normally be about 100-200 cm in length, more normally 130-180 cm in length. The diameter of the delivery mechanism is usually in the range of 0.25 to about 2.0 mm. Briefly, occlusive devices (and/or additional components) described herein are typically loaded into a carrier for introduction into a delivery catheter and introduced to the chosen site using the procedure outlined below. This procedure may be used in treating a variety of maladies. For instance, in treatment of an aneurysm, the aneurysm itself may be filled with a device as described herein which cause formation of an emboli and, at some later time, is at least partially replaced by neovascularized collagenous material formed around the implanted vaso-occlusive devices.
  • A selected site is reached through the vascular system using a collection of specifically chosen catheters and/or guide wires. It is clear that should the site be in a remote site, e.g., in the brain, methods of reaching this site are somewhat limited. One widely accepted procedure is found in U.S. Pat. No. 4,994,069 to Ritchart, et al. It utilizes a fine endovascular catheter such as is found in U.S. Pat. No. 4,739,768, to Engelson. First of all, a large catheter is introduced through an entry site in the vasculature. Typically, this would be through a femoral artery in the groin. Other entry sites sometimes chosen are found in the neck and are in general well known by physicians who practice this type of medicine. Once the introducer is in place, a guiding catheter is then used to provide a safe passageway from the entry site to a region near the site to be treated. For instance, in treating a site in the human brain, a guiding catheter would be chosen which would extend from the entry site at the femoral artery, up through the large arteries extending to the heart, around the heart through the aortic arch, and downstream through one of the arteries extending from the upper side of the aorta. A guidewire and neurovascular catheter such as that described in the Engelson patent are then placed through the guiding catheter. Once the distal end of the catheter is positioned at the site, often by locating its distal end through the use of radiopaque marker material and fluoroscopy, the catheter is cleared. For instance, if a guidewire has been used to position the catheter, it is withdrawn from the catheter and then the assembly, for example including the vaso-occlusive device at the distal end, is advanced through the catheter.
  • In certain embodiments, the delivery catheter comprises a retractable sheath (or pusher tube) at its distal end that surrounds the device to be delivered. Typically, the retractable distal sheath includes a pull back means operatively connected to the distal sheath. The catheter may be constructed and arranged such that distal end of the sheath does not extend past the distal end catheter. Alternatively, the distal end of the sheath may extend beyond the distal end of the delivery catheter, for example so that is extrudes the device directly into the target site. In certain preferred embodiments, the devices described herein are detachably linked to the distal end of a retractable sheath. FIGS. 6-9. Non-limiting examples of suitable delivery catheters will be known to those of skill in the art in view of the teachings herein. See, also, U.S. Pat. Nos. 6,425,914; 5,772,669; and 6,391,050.
  • Once the selected site has been reached, the vaso-occlusive device is extruded, for example by retracting the sheath surrounding and mounted to the device. Preferably, the vaso-occlusive device is loaded onto the pusher wire and/or tube via a mechanically or electrolytically cleavable junction (e.g., a GDC-type junction that can be severed by application of heat, electrolysis, electrodynamic activation or other means). Additionally, the vaso-occlusive device can be designed to include multiple detachment points, as described in co-owned U.S. Pat. No. 6,623,493 and 6,533,801 and International Patent publication WO 02/45596. Once detached the devices are held in place by gravity, shape, size, volume, magnetic field or combinations thereof.
  • After deployment and prior to detachment from the pusher wire and/or pusher tube, it may be preferable to lock the device in the desired configuration. This can be accomplished in any number of ways, for example, using locking elements as shown in FIGS. 6-8. As can be seen in the exemplary embodiments depicted in these Figures, the inclusion of one or more locking mechanisms helps ensure the overall configuration of the device and, accordingly, the efficient transfer of force between the upper and lower members and the surfaces of the aneurysm they contact. Detachment from the pusher wire and/or pusher tube can then be accomplished as described above.
  • An exemplary deployment scheme is shown in FIG. 9. FIG. 9A shows a side-view of the lower and central members of an exemplary device as described herein as it is advanced through the delivery catheter (17) by the pusher wire (80). Lower member (30) is constrained in linear position by delivery catheter (17) and by pusher catheter sheath (35). Extendable member (60) further comprises an expandable member (65). Central member (40) is depicted with inward-facing grooves. FIG. 9B depicts how lower member (30) assumes an expanded, three-dimensional configuration upon extrusion from pusher catheter sheath (35) and delivery catheter (17). FIG. 9C depicts the device in a locked position after expansion of expandable member (65). In addition, pusher wire is shown as detached from extendable member (60) via detachment junction (25). FIG. 9D shows the withdrawal of the delivery catheter (17) and pusher catheter (35), leaving the device in place where desired. Pusher catheter (35) is detached from lower member (30) via detachment junctions (26).
  • Modifications of the procedure and vaso-occlusive devices described above, and the methods of using them in keeping with this invention will be apparent to those having skill in this mechanical and surgical art. These variations are intended to be within the scope of the claims that follow.

Claims (31)

1. A vaso-occlusive device for placement within an aneurysm having a neck and a dome, the device comprising
a lower member having a linear configuration prior to deployment and a deployed open configuration, wherein the deployed configuration bridges the neck of the aneurysm;
an upper member having a undeployed, linear configuration prior and an open, deployed configuration, wherein the deployed configuration rests against at least a portion of the dome of the aneurysm, and
a means of adjusting the overall dimensions of the device.
2. The device of claim 1, wherein the distance between the upper and lower members is adjustable.
3. The device of claim 1, wherein the upper and lower members are contiguous.
4. The device of claim 1, wherein one or both of the upper member and lower member are compressible.
5. The device of claim 1, wherein the upper and lower members are separate, the device further comprising an adjustable central member having a proximal end connected to the lower member and distal end connected to the upper member.
6. The device of claim 5, wherein the central member comprises a compressible element.
7. The device of claim 5, wherein the central member comprises an extendable member connected to the upper member.
8. The device of claim 5, wherein the central member comprises an expandable element.
9. The device of claim 1, wherein the upper member comprises a plurality of axially moveable wires passing through the lumen of the central member, each wire comprising a distal end and a proximal end.
10. The device of claim 9, wherein the distal end of one or more of the wires is attached to the central member.
11. The device of claim 9, wherein the distal end of one or more of the wires is attached to the lower member.
12. The device of claim 1, wherein the lower and/or upper members comprise a braid configuration.
13. The device of claim 1, wherein the upper and lower members are contiguous.
14. The device of claim 1, further comprising one or more detachment junctions.
15. The device of claim 14, wherein at least one detachment junction comprises an electrolytically detachable end adapted to detach by imposition of a current thereon.
16. The device of claim 14, comprising a detachment junction positioned between the upper member and a pusher wire and one or more detachment junctions positioned between the lower member and a pusher tube.
17. The device of claim 1, further comprising one or more locking mechanisms.
18. The device of claim 17, wherein the locking mechanism comprises an expandable material.
19. The device of claim 17, wherein the locking mechanism comprises a self-expanding element.
20. The device of claim 1, wherein the upper member comprises a metal.
21. The device of claim 20, wherein the metal is selected from the group consisting of nickel, titanium, platinum, gold, tungsten, iridium and alloys or combinations thereof.
22. The device of claim 21, wherein the alloy is nitinol.
23. The device of claim 1, wherein the lower member comprises a metal selected from the group consisting of platinum, palladium, rhodium, gold, tungsten and alloys thereof.
24. The device of claim 23, wherein the lower member comprises nitinol.
25. The device of claim 23, wherein the lower member comprises a mesh or braid structure.
26. The device of claim 1, wherein the lower member comprises a film.
27. The device of claim 26, wherein the film is selected from the group consisting of a porous film, a polymer film and a metallic film.
28. The device of claim 1, further comprising an additional component.
29. The device of claim 28, wherein the additional component is bioactive.
30. A method of occluding a body cavity comprising introducing a vaso-occlusive device according to claim 1 into the body cavity.
31. The method of claim 29, wherein the body cavity is an aneurysm.
US11/031,421 2005-01-07 2005-01-07 Intra-aneurysm devices Abandoned US20060155323A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
US11/031,421 US20060155323A1 (en) 2005-01-07 2005-01-07 Intra-aneurysm devices
PCT/US2005/047349 WO2006074032A2 (en) 2005-01-07 2005-12-29 Intra-aneurysm devices
US13/887,589 US10265075B2 (en) 2005-01-07 2013-05-06 Intra-aneurysm devices
US16/389,168 US20190298379A1 (en) 2005-01-07 2019-04-19 Intra-aneurysm devices
US17/022,037 US20210052279A1 (en) 2005-01-07 2020-09-15 Intra-aneurysm devices
US17/950,660 US20230015848A1 (en) 2005-01-07 2022-09-22 Intra-Aneurysm Devices

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11/031,421 US20060155323A1 (en) 2005-01-07 2005-01-07 Intra-aneurysm devices

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US13/887,589 Continuation US10265075B2 (en) 2005-01-07 2013-05-06 Intra-aneurysm devices

Publications (1)

Publication Number Publication Date
US20060155323A1 true US20060155323A1 (en) 2006-07-13

Family

ID=36121387

Family Applications (5)

Application Number Title Priority Date Filing Date
US11/031,421 Abandoned US20060155323A1 (en) 2005-01-07 2005-01-07 Intra-aneurysm devices
US13/887,589 Active 2027-09-08 US10265075B2 (en) 2005-01-07 2013-05-06 Intra-aneurysm devices
US16/389,168 Pending US20190298379A1 (en) 2005-01-07 2019-04-19 Intra-aneurysm devices
US17/022,037 Pending US20210052279A1 (en) 2005-01-07 2020-09-15 Intra-aneurysm devices
US17/950,660 Pending US20230015848A1 (en) 2005-01-07 2022-09-22 Intra-Aneurysm Devices

Family Applications After (4)

Application Number Title Priority Date Filing Date
US13/887,589 Active 2027-09-08 US10265075B2 (en) 2005-01-07 2013-05-06 Intra-aneurysm devices
US16/389,168 Pending US20190298379A1 (en) 2005-01-07 2019-04-19 Intra-aneurysm devices
US17/022,037 Pending US20210052279A1 (en) 2005-01-07 2020-09-15 Intra-aneurysm devices
US17/950,660 Pending US20230015848A1 (en) 2005-01-07 2022-09-22 Intra-Aneurysm Devices

Country Status (2)

Country Link
US (5) US20060155323A1 (en)
WO (1) WO2006074032A2 (en)

Cited By (139)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060200234A1 (en) * 2005-03-03 2006-09-07 Hines Richard A Endovascular aneurysm treatment device and delivery system
US20080221600A1 (en) * 2006-08-17 2008-09-11 Dieck Martin S Isolation devices for the treatment of aneurysms
US20090123914A1 (en) * 2004-09-24 2009-05-14 Ingeneus Inc. Genomic Assay
US20090275974A1 (en) * 2008-05-02 2009-11-05 Philippe Marchand Filamentary devices for treatment of vascular defects
US20090287294A1 (en) * 2008-04-21 2009-11-19 Rosqueta Arturo S Braid-Ball Embolic Devices
US20100131002A1 (en) * 2008-11-24 2010-05-27 Connor Robert A Stent with a net layer to embolize and aneurysm
US20100324585A1 (en) * 2009-06-17 2010-12-23 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US20110046658A1 (en) * 2008-05-01 2011-02-24 Aneuclose Llc Aneurysm occlusion device
US20110054515A1 (en) * 2009-08-25 2011-03-03 John Bridgeman Device and method for occluding the left atrial appendage
US20110152993A1 (en) * 2009-11-05 2011-06-23 Sequent Medical Inc. Multiple layer filamentary devices or treatment of vascular defects
US20110166588A1 (en) * 2010-01-04 2011-07-07 Connor Robert A Aneurysm embolization by rotational accumulation of mass
US20110196414A1 (en) * 2010-02-05 2011-08-11 Stephen Porter Multimode occlusion and stenosis treatment apparatus and method of use
US20110202085A1 (en) * 2009-11-09 2011-08-18 Siddharth Loganathan Braid Ball Embolic Device Features
US8187315B1 (en) 2006-12-08 2012-05-29 Cardica, Inc. Partial stent for treatment of a vascular aneurysm
US8425548B2 (en) 2010-07-01 2013-04-23 Aneaclose LLC Occluding member expansion and then stent expansion for aneurysm treatment
US20130178889A1 (en) * 2009-06-17 2013-07-11 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US20130211495A1 (en) * 2009-11-09 2013-08-15 Covidien Lp Interference-relief type delivery detachment systems
US20130274863A1 (en) * 2007-06-04 2013-10-17 Sequent Medical Inc. Methods and devices for treatment of vascular defects
US8636760B2 (en) 2009-04-20 2014-01-28 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US20140039542A1 (en) * 2012-01-26 2014-02-06 Endoshape, Inc. Systems, Devices, And Methods for Delivering A Lumen Occlusion Device Using Distal And/Or Proximal Control
US8668716B2 (en) * 2006-11-13 2014-03-11 Electroformed Stents, Inc. Over-the-wire exclusion device and system for delivery
US20140350588A1 (en) * 2011-11-09 2014-11-27 Easynotes Ltd. Obstruction device
US8926681B2 (en) 2010-01-28 2015-01-06 Covidien Lp Vascular remodeling device
US8974512B2 (en) 2010-09-10 2015-03-10 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US9060886B2 (en) 2011-09-29 2015-06-23 Covidien Lp Vascular remodeling device
US9078658B2 (en) 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9089332B2 (en) 2011-03-25 2015-07-28 Covidien Lp Vascular remodeling device
US9095343B2 (en) 2005-05-25 2015-08-04 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US9179918B2 (en) 2008-07-22 2015-11-10 Covidien Lp Vascular remodeling device
US9204983B2 (en) 2005-05-25 2015-12-08 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
US9351716B2 (en) 2009-06-17 2016-05-31 Coherex Medical, Inc. Medical device and delivery system for modification of left atrial appendage and methods thereof
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US9375333B1 (en) 2015-03-06 2016-06-28 Covidien Lp Implantable device detachment systems and associated devices and methods
US9393022B2 (en) 2011-02-11 2016-07-19 Covidien Lp Two-stage deployment aneurysm embolization devices
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US9468442B2 (en) 2010-01-28 2016-10-18 Covidien Lp Vascular remodeling device
US9572584B2 (en) 2009-01-08 2017-02-21 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
JP2017511202A (en) * 2014-04-14 2017-04-20 シークエント メディカル インコーポレイテッド Devices for procedural vascular procedures
US9649115B2 (en) 2009-06-17 2017-05-16 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US9795387B2 (en) 1997-05-19 2017-10-24 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9955976B2 (en) 2013-08-16 2018-05-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US20180140305A1 (en) * 2008-05-01 2018-05-24 Aneuclose Llc Janjua Aneurysm Net with a Resilient Neck-Bridging Portion for Occluding a Cerebral Aneurysm
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
CN108451569A (en) * 2017-02-21 2018-08-28 科赫里克斯医疗股份有限公司 Medical treatment device for correcting left auricle of heart and relevant system and method
US10064628B2 (en) 2009-06-17 2018-09-04 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US10130372B2 (en) 2014-04-30 2018-11-20 Cerus Endovascular Limited Occlusion Device
EP3403596A1 (en) * 2017-05-16 2018-11-21 Universitätsklinikum Jena Implantation and anchorage system for an atrial occluder
US10265078B2 (en) 2015-04-01 2019-04-23 Boston Scientific Scimed, Inc. Systems and methods for delivery of gel embolics
US10327781B2 (en) 2012-11-13 2019-06-25 Covidien Lp Occlusive devices
US10433853B2 (en) 2014-04-18 2019-10-08 Covidien Lp Embolic medical devices
US10433988B2 (en) 2006-02-22 2019-10-08 Covidien Lp Stents having radiopaque mesh
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
US10478195B2 (en) 2016-08-04 2019-11-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US10499939B2 (en) 2013-11-13 2019-12-10 Covidien Lp Galvanically assisted attachment of medical devices to thrombus
US10548579B2 (en) 2015-07-29 2020-02-04 Cardiac Pacemakers, Inc. Left atrial appendage implant
US10548748B2 (en) 2009-06-23 2020-02-04 Covidien Lp Procedures for vascular occlusion
US10576099B2 (en) 2016-10-21 2020-03-03 Covidien Lp Injectable scaffold for treatment of intracranial aneurysms and related technology
US10595875B2 (en) 2014-12-31 2020-03-24 Endostream Medical Ltd. Device for restricting blood flow to aneurysms
US10624772B2 (en) 2011-11-04 2020-04-21 Covidien Lp Protuberant aneurysm bridging device deployment method
US10631969B2 (en) 2009-06-17 2020-04-28 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US10675036B2 (en) 2017-08-22 2020-06-09 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US10722255B2 (en) 2008-12-23 2020-07-28 Covidien Lp Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US10736758B2 (en) 2013-03-15 2020-08-11 Covidien Occlusive device
US10743882B2 (en) 2013-03-15 2020-08-18 Covidien Lp Delivery and detachment mechanisms for vascular implants
US10765542B2 (en) 2004-05-25 2020-09-08 Covidien Lp Methods and apparatus for luminal stenting
US20200305885A1 (en) * 2019-03-27 2020-10-01 DePuy Synthes Products, Inc. Aneurysm treatment device
US10806609B2 (en) 2004-05-25 2020-10-20 Covidien Lp Vascular stenting for aneurysms
US10806611B2 (en) 2010-12-06 2020-10-20 Covidien Lp Vascular remodeling device
US10828039B2 (en) 2016-06-27 2020-11-10 Covidien Lp Electrolytic detachment for implantable devices
US10828037B2 (en) 2016-06-27 2020-11-10 Covidien Lp Electrolytic detachment with fluid electrical connection
US10856879B2 (en) 2015-02-25 2020-12-08 Galaxy Therapeutics Inc. System for and method of treating aneurysms
US10856880B1 (en) 2019-05-25 2020-12-08 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
US10869672B2 (en) 2016-03-11 2020-12-22 Cents Endovascular Limited Occlusion device
US10874401B2 (en) 2014-08-08 2020-12-29 Covidien Lp Electrolytic and mechanical detachment for implant delivery systems
US10893868B2 (en) 2012-01-20 2021-01-19 Covidien Lp Aneurysm treatment coils
US10893869B2 (en) 2016-03-24 2021-01-19 Covidien Lp Thin wall constructions for vascular flow diversion
US10905432B2 (en) 2018-08-22 2021-02-02 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
US10905430B2 (en) 2018-01-24 2021-02-02 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10912569B2 (en) 2018-08-22 2021-02-09 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
US10918389B2 (en) 2004-05-25 2021-02-16 Covidien Lp Flexible vascular occluding device
US10939915B2 (en) 2018-05-31 2021-03-09 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10952878B2 (en) 2012-10-31 2021-03-23 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US10966728B2 (en) 2016-06-21 2021-04-06 Endostream Medical Ltd. Medical device for treating vascular malformations
US11045204B2 (en) 2011-05-11 2021-06-29 Covidien Lp Vascular remodeling device
US11051822B2 (en) 2016-06-28 2021-07-06 Covidien Lp Implant detachment with thermal activation
US11058430B2 (en) 2018-05-25 2021-07-13 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11065009B2 (en) 2018-02-08 2021-07-20 Covidien Lp Vascular expandable devices
US11065136B2 (en) 2018-02-08 2021-07-20 Covidien Lp Vascular expandable devices
US11076860B2 (en) 2014-03-31 2021-08-03 DePuy Synthes Products, Inc. Aneurysm occlusion device
US11076861B2 (en) 2018-10-12 2021-08-03 DePuy Synthes Products, Inc. Folded aneurysm treatment device and delivery method
US11123077B2 (en) 2018-09-25 2021-09-21 DePuy Synthes Products, Inc. Intrasaccular device positioning and deployment system
US11129621B2 (en) 2018-12-17 2021-09-28 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11134953B2 (en) 2019-02-06 2021-10-05 DePuy Synthes Products, Inc. Adhesive cover occluding device for aneurysm treatment
US11154302B2 (en) 2014-03-31 2021-10-26 DePuy Synthes Products, Inc. Aneurysm occlusion device
US11272939B2 (en) 2018-12-18 2022-03-15 DePuy Synthes Products, Inc. Intrasaccular flow diverter for treating cerebral aneurysms
US11278292B2 (en) 2019-05-21 2022-03-22 DePuy Synthes Products, Inc. Inverting braided aneurysm treatment system and method
US11291453B2 (en) 2019-03-15 2022-04-05 Sequent Medical, Inc. Filamentary devices having a flexible joint for treatment of vascular defects
US11317921B2 (en) 2019-03-15 2022-05-03 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
CN114504356A (en) * 2021-06-23 2022-05-17 上海心玮医疗科技股份有限公司 Three-dimensional self-adaptive intracranial aneurysm plugging device
US11337706B2 (en) 2019-03-27 2022-05-24 DePuy Synthes Products, Inc. Aneurysm treatment device
US11357511B2 (en) 2008-05-01 2022-06-14 Aneuclose Llc Intrasacular aneurysm occlusion device with globular first configuration and bowl-shaped second configuration
US11369355B2 (en) 2019-06-17 2022-06-28 Coherex Medical, Inc. Medical device and system for occluding a tissue opening and method thereof
US11389170B2 (en) 2016-09-16 2022-07-19 Endoshape, Inc. Occlusive implants with fiber-based release structures
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods
US11406392B2 (en) 2018-12-12 2022-08-09 DePuy Synthes Products, Inc. Aneurysm occluding device for use with coagulating agents
US11413046B2 (en) 2019-05-21 2022-08-16 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11457926B2 (en) 2019-12-18 2022-10-04 DePuy Synthes Products, Inc. Implant having an intrasaccular section and intravascular section
US11464518B2 (en) * 2008-05-01 2022-10-11 Aneuclose Llc Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms
US11471163B2 (en) 2008-05-01 2022-10-18 Aneuclose Llc Intrasaccular aneurysm occlusion device with net or mesh expanded by string-of-pearls embolies
US11471164B2 (en) 2008-05-01 2022-10-18 Aneuclose Llc Methods of occluding a cerebral aneurysm by inserting embolic members or material into an intrasacular implant
US11471162B2 (en) 2015-12-07 2022-10-18 Cerus Endovascular Limited Occlusion device
US11484322B2 (en) 2018-01-03 2022-11-01 Aneuclose Llc Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac
US11497504B2 (en) 2019-05-21 2022-11-15 DePuy Synthes Products, Inc. Aneurysm treatment with pushable implanted braid
US11540838B2 (en) 2019-08-30 2023-01-03 Boston Scientific Scimed, Inc. Left atrial appendage implant with sealing disk
US11559309B2 (en) 2019-03-15 2023-01-24 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11583288B2 (en) 2018-08-08 2023-02-21 DePuy Synthes Products, Inc. Delivery of embolic braid
US11583289B2 (en) 2008-05-01 2023-02-21 Aneuclose Llc Aneurysm-occluding mesh ribbon with a series of loops or segments having distal-to-proximal variation in size, shape, and/or orientation
US11583282B2 (en) 2019-05-21 2023-02-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11596412B2 (en) 2018-05-25 2023-03-07 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11602350B2 (en) 2019-12-05 2023-03-14 DePuy Synthes Products, Inc. Intrasaccular inverting braid with highly flexible fill material
US11607226B2 (en) 2019-05-21 2023-03-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device with corrugations
US11633818B2 (en) 2019-11-04 2023-04-25 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11672542B2 (en) 2019-05-21 2023-06-13 DePuy Synthes Products, Inc. Aneurysm treatment with pushable ball segment
US11672543B2 (en) 2017-02-23 2023-06-13 DePuy Synthes Products, Inc. Aneurysm method and system
US11812971B2 (en) 2017-08-21 2023-11-14 Cerus Endovascular Limited Occlusion device
US11812969B2 (en) 2020-12-03 2023-11-14 Coherex Medical, Inc. Medical device and system for occluding a tissue opening and method thereof
US11812970B2 (en) 2019-01-17 2023-11-14 Endostream Medical Ltd. Vascular-malformation implant system
US11864770B2 (en) 2015-09-23 2024-01-09 Covidien Lp Occlusive devices
US20240023970A1 (en) * 2008-05-01 2024-01-25 Aneuclose Llc Janjua Aneurysm Net and Other Intrasacular Aneurysm Occlusion Devices
US11903589B2 (en) 2020-03-24 2024-02-20 Boston Scientific Scimed, Inc. Medical system for treating a left atrial appendage
US11931041B2 (en) 2020-05-12 2024-03-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11944314B2 (en) 2019-07-17 2024-04-02 Boston Scientific Scimed, Inc. Left atrial appendage implant with continuous covering
US11969171B2 (en) 2023-04-10 2024-04-30 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060155323A1 (en) * 2005-01-07 2006-07-13 Porter Stephen C Intra-aneurysm devices
DE102011102955B4 (en) * 2011-05-31 2018-05-03 Acandis Gmbh & Co. Kg Medical implant for arranging a hollow body, in particular an aneurysm, and method for producing a medical implant
DE102012102844B4 (en) * 2012-04-02 2020-03-19 Acandis Gmbh Occlusion device for implantation within an aneurysm and arrangement with such an occlusion device
US20150133989A1 (en) * 2012-04-20 2015-05-14 Inceptus Medical, Llc Expandable occlusion devices and methods of use
US9259237B2 (en) 2013-07-12 2016-02-16 Inceptus Medical, Llc Methods and apparatus for treating pulmonary embolism
WO2017106567A1 (en) * 2015-12-15 2017-06-22 Nsvascular, Inc. Intrasaccular thin-film flow diverters and related methods
EP3463109A4 (en) 2016-05-26 2020-01-08 Nanostructures, Inc. System and methods for embolized occlusion of neurovascular aneurysms
CN113215721B (en) 2016-10-14 2023-02-17 因赛普特斯医学有限责任公司 Knitting machine and method of use
US10376267B2 (en) 2017-02-24 2019-08-13 Inceptus Medical, Llc Vascular occlusion devices and methods
US11885051B2 (en) 2017-10-14 2024-01-30 Inceptus Medical, Llc Braiding machine and methods of use
US11185335B2 (en) 2018-01-19 2021-11-30 Galaxy Therapeutics Inc. System for and method of treating aneurysms
CN111936063A (en) * 2018-01-31 2020-11-13 纳米结构公司 Vascular occlusion device using thin film nitinol foil
CN109745094B (en) * 2018-12-29 2021-09-03 先健科技(深圳)有限公司 Plugging device
DE102020118301A1 (en) * 2019-12-23 2021-06-24 Femtos Gmbh Implant for the treatment of aneurysms

Citations (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174851A (en) * 1961-12-01 1965-03-23 William J Buehler Nickel-base alloys
US3351463A (en) * 1965-08-20 1967-11-07 Alexander G Rozner High strength nickel-base alloys
US3753700A (en) * 1970-07-02 1973-08-21 Raychem Corp Heat recoverable alloy
US4739768A (en) * 1986-06-02 1988-04-26 Target Therapeutics Catheter for guide-wire tracking
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5284488A (en) * 1992-12-23 1994-02-08 Sideris Eleftherios B Adjustable devices for the occlusion of cardiac defects
US5342393A (en) * 1992-08-27 1994-08-30 Duke University Method and device for vascular repair
US5350399A (en) * 1991-09-23 1994-09-27 Jay Erlebacher Percutaneous arterial puncture seal device and insertion tool therefore
US5354295A (en) * 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5514076A (en) * 1994-01-27 1996-05-07 Flexmedics Corporation Surgical retractor
US5634936A (en) * 1995-02-06 1997-06-03 Scimed Life Systems, Inc. Device for closing a septal defect
US5690666A (en) * 1992-11-18 1997-11-25 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
US5690667A (en) * 1996-09-26 1997-11-25 Target Therapeutics Vasoocclusion coil having a polymer tip
US5733294A (en) * 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US5772669A (en) * 1996-09-27 1998-06-30 Scimed Life Systems, Inc. Stent deployment catheter with retractable sheath
US6022351A (en) * 1999-02-23 2000-02-08 Bremer; Paul W. Skull closure device and procedure
US6168622B1 (en) * 1996-01-24 2001-01-02 Microvena Corporation Method and apparatus for occluding aneurysms
US6280457B1 (en) * 1999-06-04 2001-08-28 Scimed Life Systems, Inc. Polymer covered vaso-occlusive devices and methods of producing such devices
US6299627B1 (en) * 1998-06-18 2001-10-09 Target Therapeutics, Inc. Water-soluble coating for bioactive vasoocclusive devices
US6375668B1 (en) * 1999-06-02 2002-04-23 Hanson S. Gifford Devices and methods for treating vascular malformations
US6379368B1 (en) * 1999-05-13 2002-04-30 Cardia, Inc. Occlusion device with non-thrombogenic properties
US6391050B1 (en) * 2000-02-29 2002-05-21 Scimed Life Systems, Inc. Self-expanding stent delivery system
US6425914B1 (en) * 1997-08-29 2002-07-30 Target Therapeutics, Inc. Fast-detaching electrically insulated implant
US6533801B2 (en) * 1998-02-18 2003-03-18 Target Therapeutics, Inc. Vaso-occlusive member assembly with multiple detaching points
US6585754B2 (en) * 2001-05-29 2003-07-01 Scimed Life Systems, Inc. Absorbable implantable vaso-occlusive member
US20030195553A1 (en) * 2002-04-12 2003-10-16 Scimed Life Systems, Inc. System and method for retaining vaso-occlusive devices within an aneurysm
US20030220666A1 (en) * 2002-05-24 2003-11-27 Scimed Life Systems, Inc. Solid embolic material with variable expansion
US6669721B1 (en) * 1998-06-04 2003-12-30 New York University Endovascular thin film devices and methods for treating and preventing stroke

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4932975A (en) * 1989-10-16 1990-06-12 Vanderbilt University Vertebral prosthesis
US5645558A (en) * 1995-04-20 1997-07-08 Medical University Of South Carolina Anatomically shaped vasoocclusive device and method of making the same
US6086577A (en) * 1997-08-13 2000-07-11 Scimed Life Systems, Inc. Detachable aneurysm neck bridge (III)
US5944738A (en) * 1998-02-06 1999-08-31 Aga Medical Corporation Percutaneous catheter directed constricting occlusion device
ATE454098T1 (en) * 1998-02-10 2010-01-15 Artemis Medical Inc OCCLUSION, ANCHORING, CHIPING OR POWER CONTROL DEVICE
US5925060A (en) * 1998-03-13 1999-07-20 B. Braun Celsa Covered self-expanding vascular occlusion device
US6165193A (en) * 1998-07-06 2000-12-26 Microvention, Inc. Vascular embolization with an expansible implant
US6346117B1 (en) * 2000-03-02 2002-02-12 Prodesco, Inc. Bag for use in the intravascular treatment of saccular aneurysms
US6855154B2 (en) * 2000-08-11 2005-02-15 University Of Louisville Research Foundation, Inc. Endovascular aneurysm treatment device and method
US6589265B1 (en) * 2000-10-31 2003-07-08 Endovascular Technologies, Inc. Intrasaccular embolic device
US20020072791A1 (en) 2000-12-07 2002-06-13 Eder Joseph C. Light-activated multi-point detachment mechanism
US20020082620A1 (en) 2000-12-27 2002-06-27 Elaine Lee Bioactive materials for aneurysm repair
US20030097169A1 (en) * 2001-02-26 2003-05-22 Brucker Gregory G. Bifurcated stent and delivery system
ATE491821T1 (en) * 2001-06-11 2011-01-15 Ev3 Inc METHOD FOR TRAINING NITINOL WIRE
US6793665B2 (en) * 2001-06-18 2004-09-21 Rex Medical, L.P. Multiple access vein filter
US6783538B2 (en) * 2001-06-18 2004-08-31 Rex Medical, L.P Removable vein filter
US6623506B2 (en) * 2001-06-18 2003-09-23 Rex Medical, L.P Vein filter
US20030028209A1 (en) * 2001-07-31 2003-02-06 Clifford Teoh Expandable body cavity liner device
US7670302B2 (en) 2001-12-18 2010-03-02 Boston Scientific Scimed, Inc. Super elastic guidewire with shape retention tip
US6984246B2 (en) * 2003-06-06 2006-01-10 Tain-Yew Shi Artificial intervertebral disc flexibly oriented by spring-reinforced bellows
US8777974B2 (en) * 2004-03-19 2014-07-15 Aga Medical Corporation Multi-layer braided structures for occluding vascular defects
US20060155323A1 (en) * 2005-01-07 2006-07-13 Porter Stephen C Intra-aneurysm devices
EP2279023B1 (en) * 2008-05-02 2020-12-02 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
EP2389141B1 (en) * 2009-01-22 2018-12-26 Cornell University Apparatus for restricting flow through the wall of a lumen
US20110202085A1 (en) * 2009-11-09 2011-08-18 Siddharth Loganathan Braid Ball Embolic Device Features
US9504474B2 (en) * 2011-05-23 2016-11-29 Stryker Corporation Vaso-occlusive devices with in-situ stiffening
US9078658B2 (en) * 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9629635B2 (en) * 2014-04-14 2017-04-25 Sequent Medical, Inc. Devices for therapeutic vascular procedures

Patent Citations (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174851A (en) * 1961-12-01 1965-03-23 William J Buehler Nickel-base alloys
US3351463A (en) * 1965-08-20 1967-11-07 Alexander G Rozner High strength nickel-base alloys
US3753700A (en) * 1970-07-02 1973-08-21 Raychem Corp Heat recoverable alloy
US4739768B1 (en) * 1986-06-02 1994-11-15 Target Therapeutics Inc Catheter for guide-wire tracking
US4739768A (en) * 1986-06-02 1988-04-26 Target Therapeutics Catheter for guide-wire tracking
US4739768B2 (en) * 1986-06-02 1995-10-24 Target Therapeutics Inc Catheter for guide-wire tracking
US4994069A (en) * 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
US5122136A (en) * 1990-03-13 1992-06-16 The Regents Of The University Of California Endovascular electrolytically detachable guidewire tip for the electroformation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5354295A (en) * 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
US5350399A (en) * 1991-09-23 1994-09-27 Jay Erlebacher Percutaneous arterial puncture seal device and insertion tool therefore
US5342393A (en) * 1992-08-27 1994-08-30 Duke University Method and device for vascular repair
US5382259A (en) * 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5826587A (en) * 1992-11-18 1998-10-27 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
US5690666A (en) * 1992-11-18 1997-11-25 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
US6458119B1 (en) * 1992-11-18 2002-10-01 Target Therapeutics, Inc. Ultrasoft embolism devices and process for using them
US5284488A (en) * 1992-12-23 1994-02-08 Sideris Eleftherios B Adjustable devices for the occlusion of cardiac defects
US5514076A (en) * 1994-01-27 1996-05-07 Flexmedics Corporation Surgical retractor
US5634936A (en) * 1995-02-06 1997-06-03 Scimed Life Systems, Inc. Device for closing a septal defect
US6168622B1 (en) * 1996-01-24 2001-01-02 Microvena Corporation Method and apparatus for occluding aneurysms
US5733294A (en) * 1996-02-28 1998-03-31 B. Braun Medical, Inc. Self expanding cardiovascular occlusion device, method of using and method of making the same
US5690667A (en) * 1996-09-26 1997-11-25 Target Therapeutics Vasoocclusion coil having a polymer tip
US5772669A (en) * 1996-09-27 1998-06-30 Scimed Life Systems, Inc. Stent deployment catheter with retractable sheath
US6425914B1 (en) * 1997-08-29 2002-07-30 Target Therapeutics, Inc. Fast-detaching electrically insulated implant
US6623493B2 (en) * 1998-02-18 2003-09-23 Target Therapeutics, Inc. Vaso-occlusive member assembly with multiple detaching points
US6533801B2 (en) * 1998-02-18 2003-03-18 Target Therapeutics, Inc. Vaso-occlusive member assembly with multiple detaching points
US6669721B1 (en) * 1998-06-04 2003-12-30 New York University Endovascular thin film devices and methods for treating and preventing stroke
US6299627B1 (en) * 1998-06-18 2001-10-09 Target Therapeutics, Inc. Water-soluble coating for bioactive vasoocclusive devices
US6022351A (en) * 1999-02-23 2000-02-08 Bremer; Paul W. Skull closure device and procedure
US6379368B1 (en) * 1999-05-13 2002-04-30 Cardia, Inc. Occlusion device with non-thrombogenic properties
US6375668B1 (en) * 1999-06-02 2002-04-23 Hanson S. Gifford Devices and methods for treating vascular malformations
US6746468B1 (en) * 1999-06-02 2004-06-08 Concentric Medical, Inc. Devices and methods for treating vascular malformations
US6280457B1 (en) * 1999-06-04 2001-08-28 Scimed Life Systems, Inc. Polymer covered vaso-occlusive devices and methods of producing such devices
US6391050B1 (en) * 2000-02-29 2002-05-21 Scimed Life Systems, Inc. Self-expanding stent delivery system
US6585754B2 (en) * 2001-05-29 2003-07-01 Scimed Life Systems, Inc. Absorbable implantable vaso-occlusive member
US20030195553A1 (en) * 2002-04-12 2003-10-16 Scimed Life Systems, Inc. System and method for retaining vaso-occlusive devices within an aneurysm
US20030220666A1 (en) * 2002-05-24 2003-11-27 Scimed Life Systems, Inc. Solid embolic material with variable expansion

Cited By (261)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9795387B2 (en) 1997-05-19 2017-10-24 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US11771433B2 (en) 2004-05-25 2023-10-03 Covidien Lp Flexible vascular occluding device
US11666465B2 (en) 2004-05-25 2023-06-06 Covidien Lp Vascular stenting for aneurysms
US10918389B2 (en) 2004-05-25 2021-02-16 Covidien Lp Flexible vascular occluding device
US10765542B2 (en) 2004-05-25 2020-09-08 Covidien Lp Methods and apparatus for luminal stenting
US10806609B2 (en) 2004-05-25 2020-10-20 Covidien Lp Vascular stenting for aneurysms
US20090123914A1 (en) * 2004-09-24 2009-05-14 Ingeneus Inc. Genomic Assay
US20060200234A1 (en) * 2005-03-03 2006-09-07 Hines Richard A Endovascular aneurysm treatment device and delivery system
US9204983B2 (en) 2005-05-25 2015-12-08 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9095343B2 (en) 2005-05-25 2015-08-04 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US10322018B2 (en) 2005-05-25 2019-06-18 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9198666B2 (en) 2005-05-25 2015-12-01 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US9381104B2 (en) 2005-05-25 2016-07-05 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US10064747B2 (en) 2005-05-25 2018-09-04 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US10433988B2 (en) 2006-02-22 2019-10-08 Covidien Lp Stents having radiopaque mesh
US11382777B2 (en) 2006-02-22 2022-07-12 Covidien Lp Stents having radiopaque mesh
US20080221600A1 (en) * 2006-08-17 2008-09-11 Dieck Martin S Isolation devices for the treatment of aneurysms
US8668716B2 (en) * 2006-11-13 2014-03-11 Electroformed Stents, Inc. Over-the-wire exclusion device and system for delivery
US8187315B1 (en) 2006-12-08 2012-05-29 Cardica, Inc. Partial stent for treatment of a vascular aneurysm
US11179159B2 (en) 2007-06-04 2021-11-23 Sequent Medical, Inc. Methods and devices for treatment of vascular defects
US20130274863A1 (en) * 2007-06-04 2013-10-17 Sequent Medical Inc. Methods and devices for treatment of vascular defects
US9259337B2 (en) * 2007-06-04 2016-02-16 Sequent Medical, Inc. Methods and devices for treatment of vascular defects
US20140052233A1 (en) * 2007-06-04 2014-02-20 Sequent Medical Inc. Methods and devices for treatment of vascular defects
US11154303B2 (en) 2007-10-19 2021-10-26 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US8142456B2 (en) 2008-04-21 2012-03-27 Nfocus Neuromedical, Inc. Braid-ball embolic devices
US8747597B2 (en) 2008-04-21 2014-06-10 Covidien Lp Methods for making braid-ball occlusion devices
US8696701B2 (en) 2008-04-21 2014-04-15 Covidien Lp Braid-ball embolic devices
US9039726B2 (en) 2008-04-21 2015-05-26 Covidien Lp Filamentary devices for treatment of vascular defects
US9585669B2 (en) 2008-04-21 2017-03-07 Covidien Lp Multiple layer filamentary devices for treatment of vascular defects
US20090287294A1 (en) * 2008-04-21 2009-11-19 Rosqueta Arturo S Braid-Ball Embolic Devices
US11844528B2 (en) 2008-04-21 2023-12-19 Covidien Lp Multiple layer filamentary devices for treatment of vascular defects
US20180140305A1 (en) * 2008-05-01 2018-05-24 Aneuclose Llc Janjua Aneurysm Net with a Resilient Neck-Bridging Portion for Occluding a Cerebral Aneurysm
US10028747B2 (en) 2008-05-01 2018-07-24 Aneuclose Llc Coils with a series of proximally-and-distally-connected loops for occluding a cerebral aneurysm
US8974487B2 (en) 2008-05-01 2015-03-10 Aneuclose Llc Aneurysm occlusion device
US20240023970A1 (en) * 2008-05-01 2024-01-25 Aneuclose Llc Janjua Aneurysm Net and Other Intrasacular Aneurysm Occlusion Devices
US11357511B2 (en) 2008-05-01 2022-06-14 Aneuclose Llc Intrasacular aneurysm occlusion device with globular first configuration and bowl-shaped second configuration
US11464518B2 (en) * 2008-05-01 2022-10-11 Aneuclose Llc Proximal concave neck bridge with central lumen and distal net for occluding cerebral aneurysms
US11471163B2 (en) 2008-05-01 2022-10-18 Aneuclose Llc Intrasaccular aneurysm occlusion device with net or mesh expanded by string-of-pearls embolies
US11471164B2 (en) 2008-05-01 2022-10-18 Aneuclose Llc Methods of occluding a cerebral aneurysm by inserting embolic members or material into an intrasacular implant
US20110046658A1 (en) * 2008-05-01 2011-02-24 Aneuclose Llc Aneurysm occlusion device
US10716573B2 (en) * 2008-05-01 2020-07-21 Aneuclose Janjua aneurysm net with a resilient neck-bridging portion for occluding a cerebral aneurysm
US11944316B2 (en) * 2008-05-01 2024-04-02 Aneuclose Llc Janjua aneurysm net and other intrasacular aneurysm occlusion devices
US11583289B2 (en) 2008-05-01 2023-02-21 Aneuclose Llc Aneurysm-occluding mesh ribbon with a series of loops or segments having distal-to-proximal variation in size, shape, and/or orientation
CN106974691A (en) * 2008-05-02 2017-07-25 斯昆特医疗公司 Thread device for treating vascular defects
US10610231B2 (en) 2008-05-02 2020-04-07 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
CN102119040A (en) * 2008-05-02 2011-07-06 斯昆特医疗公司 Filamentary devices for treatment of vascular defects
US9597087B2 (en) * 2008-05-02 2017-03-21 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US20090275974A1 (en) * 2008-05-02 2009-11-05 Philippe Marchand Filamentary devices for treatment of vascular defects
US10610389B2 (en) 2008-05-13 2020-04-07 Covidien Lp Braid implant delivery systems
US11707371B2 (en) 2008-05-13 2023-07-25 Covidien Lp Braid implant delivery systems
US9675482B2 (en) 2008-05-13 2017-06-13 Covidien Lp Braid implant delivery systems
US9179918B2 (en) 2008-07-22 2015-11-10 Covidien Lp Vascular remodeling device
US20100131002A1 (en) * 2008-11-24 2010-05-27 Connor Robert A Stent with a net layer to embolize and aneurysm
US10722255B2 (en) 2008-12-23 2020-07-28 Covidien Lp Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US10420564B2 (en) 2009-01-08 2019-09-24 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US10695070B2 (en) 2009-01-08 2020-06-30 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9750505B2 (en) 2009-01-08 2017-09-05 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9572584B2 (en) 2009-01-08 2017-02-21 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US8636760B2 (en) 2009-04-20 2014-01-28 Covidien Lp System and method for delivering and deploying an occluding device within a vessel
US10076337B2 (en) * 2009-06-17 2018-09-18 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US20140207169A1 (en) * 2009-06-17 2014-07-24 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US10582930B2 (en) 2009-06-17 2020-03-10 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US11253262B2 (en) 2009-06-17 2022-02-22 Coherex Medical, Inc. Delivery device, system, and method thereof
US10537332B2 (en) 2009-06-17 2020-01-21 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9649115B2 (en) 2009-06-17 2017-05-16 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US20130178889A1 (en) * 2009-06-17 2013-07-11 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9693781B2 (en) * 2009-06-17 2017-07-04 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9693780B2 (en) 2009-06-17 2017-07-04 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US20160262767A1 (en) * 2009-06-17 2016-09-15 Coherex Medical, Inc. Medical device and delivery system for modification of left atrial appendage and methods thereof
US10631969B2 (en) 2009-06-17 2020-04-28 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US11918227B2 (en) 2009-06-17 2024-03-05 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US11540837B2 (en) 2009-06-17 2023-01-03 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US10758240B2 (en) 2009-06-17 2020-09-01 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US20100324585A1 (en) * 2009-06-17 2010-12-23 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US10772637B2 (en) * 2009-06-17 2020-09-15 Coherex Medical, Inc. Medical device and delivery system for modification of left atrial appendage and methods thereof
US10064628B2 (en) 2009-06-17 2018-09-04 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9883864B2 (en) * 2009-06-17 2018-02-06 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US11000289B2 (en) 2009-06-17 2021-05-11 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US9351716B2 (en) 2009-06-17 2016-05-31 Coherex Medical, Inc. Medical device and delivery system for modification of left atrial appendage and methods thereof
US10582929B2 (en) 2009-06-17 2020-03-10 Coherex Medical, Inc. Medical device for modification of left atrial appendage and related systems and methods
US10548748B2 (en) 2009-06-23 2020-02-04 Covidien Lp Procedures for vascular occlusion
US11564817B2 (en) 2009-06-23 2023-01-31 Covidien Lp Procedures for vascular occlusion
US9913652B2 (en) 2009-08-25 2018-03-13 Atritech, Inc. Device and method for occluding the left atrial appendage
US20110054515A1 (en) * 2009-08-25 2011-03-03 John Bridgeman Device and method for occluding the left atrial appendage
US9918720B2 (en) 2009-11-05 2018-03-20 Sequent Medical Inc. Multiple layer filamentary devices for treatment of vascular defects
US20110152993A1 (en) * 2009-11-05 2011-06-23 Sequent Medical Inc. Multiple layer filamentary devices or treatment of vascular defects
US9814562B2 (en) * 2009-11-09 2017-11-14 Covidien Lp Interference-relief type delivery detachment systems
US20110202085A1 (en) * 2009-11-09 2011-08-18 Siddharth Loganathan Braid Ball Embolic Device Features
US20130211495A1 (en) * 2009-11-09 2013-08-15 Covidien Lp Interference-relief type delivery detachment systems
US9095342B2 (en) 2009-11-09 2015-08-04 Covidien Lp Braid ball embolic device features
US9358140B1 (en) 2009-11-18 2016-06-07 Aneuclose Llc Stent with outer member to embolize an aneurysm
US20110166588A1 (en) * 2010-01-04 2011-07-07 Connor Robert A Aneurysm embolization by rotational accumulation of mass
US8906057B2 (en) 2010-01-04 2014-12-09 Aneuclose Llc Aneurysm embolization by rotational accumulation of mass
US9468442B2 (en) 2010-01-28 2016-10-18 Covidien Lp Vascular remodeling device
US8926681B2 (en) 2010-01-28 2015-01-06 Covidien Lp Vascular remodeling device
US20110196414A1 (en) * 2010-02-05 2011-08-11 Stephen Porter Multimode occlusion and stenosis treatment apparatus and method of use
US8425548B2 (en) 2010-07-01 2013-04-23 Aneaclose LLC Occluding member expansion and then stent expansion for aneurysm treatment
US9855052B2 (en) 2010-09-10 2018-01-02 Covidien Lp Devices and methods for the treatment of vascular defects
US10675037B2 (en) 2010-09-10 2020-06-09 Covidien Lp Devices and methods for the treatment of vascular defects
US8998947B2 (en) 2010-09-10 2015-04-07 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US10064627B2 (en) 2010-09-10 2018-09-04 Covidien Lp Devices and methods for the treatment of vascular defects
US11534176B2 (en) 2010-09-10 2022-12-27 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US10617426B2 (en) 2010-09-10 2020-04-14 Covidien Lp Devices and methods for the treatment of vascular defects
US10617427B2 (en) 2010-09-10 2020-04-14 Covidien Lp Devices and methods for the treatment of vascular defects
US9855051B2 (en) 2010-09-10 2018-01-02 Covidien Lp Devices and methods for the treatment of vascular defects
US8974512B2 (en) 2010-09-10 2015-03-10 Medina Medical, Inc. Devices and methods for the treatment of vascular defects
US10939916B2 (en) 2010-09-10 2021-03-09 Covidien Lp Devices and methods for the treatment of vascular defects
US9844382B2 (en) 2010-09-10 2017-12-19 Covidien Lp Devices and methods for the treatment of vascular defects
US10898200B2 (en) 2010-09-10 2021-01-26 Covidien Lp Devices and methods for the treatment of vascular defects
US10806611B2 (en) 2010-12-06 2020-10-20 Covidien Lp Vascular remodeling device
US11690741B2 (en) 2010-12-06 2023-07-04 Covidien Lp Vascular remodeling device
US9393022B2 (en) 2011-02-11 2016-07-19 Covidien Lp Two-stage deployment aneurysm embolization devices
US11147563B2 (en) 2011-03-25 2021-10-19 Covidien Lp Vascular remodeling device
US10004511B2 (en) 2011-03-25 2018-06-26 Covidien Lp Vascular remodeling device
US9089332B2 (en) 2011-03-25 2015-07-28 Covidien Lp Vascular remodeling device
US11045204B2 (en) 2011-05-11 2021-06-29 Covidien Lp Vascular remodeling device
US9138232B2 (en) 2011-05-24 2015-09-22 Aneuclose Llc Aneurysm occlusion by rotational dispensation of mass
US9060886B2 (en) 2011-09-29 2015-06-23 Covidien Lp Vascular remodeling device
US10828182B2 (en) 2011-09-29 2020-11-10 Covidien Lp Vascular remodeling device
US11654037B2 (en) 2011-09-29 2023-05-23 Covidien Lp Vascular remodeling device
US10624772B2 (en) 2011-11-04 2020-04-21 Covidien Lp Protuberant aneurysm bridging device deployment method
US11406519B2 (en) 2011-11-04 2022-08-09 Covidien Lp Protuberant aneurysm bridging device deployment method
US20140350588A1 (en) * 2011-11-09 2014-11-27 Easynotes Ltd. Obstruction device
US10219931B2 (en) * 2011-11-09 2019-03-05 Easynotes Ltd. Obstruction device
US10893868B2 (en) 2012-01-20 2021-01-19 Covidien Lp Aneurysm treatment coils
US9339275B2 (en) * 2012-01-26 2016-05-17 Endoshape, Inc. Systems, devices, and methods for delivering a lumen occlusion device using distal and/or proximal control
US10206685B2 (en) 2012-01-26 2019-02-19 Endoshape, Inc. Systems, devices, and methods for delivering a lumen occlusion device using distal and/or proximal control
US20140039542A1 (en) * 2012-01-26 2014-02-06 Endoshape, Inc. Systems, Devices, And Methods for Delivering A Lumen Occlusion Device Using Distal And/Or Proximal Control
US9155647B2 (en) 2012-07-18 2015-10-13 Covidien Lp Methods and apparatus for luminal stenting
US9877856B2 (en) 2012-07-18 2018-01-30 Covidien Lp Methods and apparatus for luminal stenting
US10952878B2 (en) 2012-10-31 2021-03-23 Covidien Lp Methods and systems for increasing a density of a region of a vascular device
US9924959B2 (en) 2012-11-06 2018-03-27 Covidien Lp Multi-pivot thrombectomy device
US11406405B2 (en) 2012-11-06 2022-08-09 Covidien Lp Multi-pivot thrombectomy device
US9314248B2 (en) 2012-11-06 2016-04-19 Covidien Lp Multi-pivot thrombectomy device
US10327781B2 (en) 2012-11-13 2019-06-25 Covidien Lp Occlusive devices
US11786253B2 (en) 2012-11-13 2023-10-17 Covidien Lp Occlusive devices
US20190343532A1 (en) * 2012-11-13 2019-11-14 Covidien Lp Occlusive devices
US11690628B2 (en) 2012-11-13 2023-07-04 Covidien Lp Occlusive devices
US9295571B2 (en) 2013-01-17 2016-03-29 Covidien Lp Methods and apparatus for luminal stenting
US9901472B2 (en) 2013-01-17 2018-02-27 Covidien Lp Methods and apparatus for luminal stenting
US9463105B2 (en) 2013-03-14 2016-10-11 Covidien Lp Methods and apparatus for luminal stenting
US11389309B2 (en) 2013-03-15 2022-07-19 Covidien Lp Occlusive device
US10736758B2 (en) 2013-03-15 2020-08-11 Covidien Occlusive device
US10743882B2 (en) 2013-03-15 2020-08-18 Covidien Lp Delivery and detachment mechanisms for vascular implants
US11490896B2 (en) 2013-03-15 2022-11-08 Covidien Lp Delivery and detachment mechanisms for vascular implants
US10939914B2 (en) 2013-08-16 2021-03-09 Sequent Medical, Inc. Filamentary devices for the treatment of vascular defects
US10136896B2 (en) 2013-08-16 2018-11-27 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US10813645B2 (en) 2013-08-16 2020-10-27 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9295473B2 (en) 2013-08-16 2016-03-29 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9198670B2 (en) 2013-08-16 2015-12-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9492174B2 (en) 2013-08-16 2016-11-15 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US9955976B2 (en) 2013-08-16 2018-05-01 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11723667B2 (en) 2013-08-16 2023-08-15 Microvention, Inc. Filamentary devices for treatment of vascular defects
US9078658B2 (en) 2013-08-16 2015-07-14 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US10499939B2 (en) 2013-11-13 2019-12-10 Covidien Lp Galvanically assisted attachment of medical devices to thrombus
US11317931B2 (en) 2013-11-13 2022-05-03 Covidien Lp Electrically assisted attachment of medical devices to thrombus
US11154302B2 (en) 2014-03-31 2021-10-26 DePuy Synthes Products, Inc. Aneurysm occlusion device
US11076860B2 (en) 2014-03-31 2021-08-03 DePuy Synthes Products, Inc. Aneurysm occlusion device
JP2017511202A (en) * 2014-04-14 2017-04-20 シークエント メディカル インコーポレイテッド Devices for procedural vascular procedures
US9629635B2 (en) 2014-04-14 2017-04-25 Sequent Medical, Inc. Devices for therapeutic vascular procedures
US11678886B2 (en) 2014-04-14 2023-06-20 Microvention, Inc. Devices for therapeutic vascular procedures
US10433853B2 (en) 2014-04-18 2019-10-08 Covidien Lp Embolic medical devices
US11596414B2 (en) 2014-04-18 2023-03-07 Covidien Lp Embolic medical devices
US11389174B2 (en) 2014-04-30 2022-07-19 Cerus Endovascular Limited Occlusion device
US11284901B2 (en) 2014-04-30 2022-03-29 Cerus Endovascular Limited Occlusion device
US10130372B2 (en) 2014-04-30 2018-11-20 Cerus Endovascular Limited Occlusion Device
US10874401B2 (en) 2014-08-08 2020-12-29 Covidien Lp Electrolytic and mechanical detachment for implant delivery systems
US11839380B2 (en) 2014-08-08 2023-12-12 Covidien Lp Electrolytic and mechanical detachment for implant delivery systems
US10595875B2 (en) 2014-12-31 2020-03-24 Endostream Medical Ltd. Device for restricting blood flow to aneurysms
US11883031B2 (en) 2014-12-31 2024-01-30 Endostream Medical Ltd. Device for restricting blood flow to aneurysms
JP2022028723A (en) * 2015-02-25 2022-02-16 ギャラクシー セラピューティクス インコーポレイテッド System for and method for treating aneurysms
US10856879B2 (en) 2015-02-25 2020-12-08 Galaxy Therapeutics Inc. System for and method of treating aneurysms
US11883032B2 (en) 2015-02-25 2024-01-30 Galaxy Therapeutics, Inc. System for and method of treating aneurysms
US9375333B1 (en) 2015-03-06 2016-06-28 Covidien Lp Implantable device detachment systems and associated devices and methods
US10265078B2 (en) 2015-04-01 2019-04-23 Boston Scientific Scimed, Inc. Systems and methods for delivery of gel embolics
US11877753B2 (en) 2015-04-01 2024-01-23 Boston Scientific Scimed, Inc. Systems and methods for delivery of gel embolics
US10548579B2 (en) 2015-07-29 2020-02-04 Cardiac Pacemakers, Inc. Left atrial appendage implant
US10478194B2 (en) 2015-09-23 2019-11-19 Covidien Lp Occlusive devices
US11864770B2 (en) 2015-09-23 2024-01-09 Covidien Lp Occlusive devices
US11357510B2 (en) 2015-09-23 2022-06-14 Covidien Lp Occlusive devices
US11471162B2 (en) 2015-12-07 2022-10-18 Cerus Endovascular Limited Occlusion device
US11648013B2 (en) 2016-03-11 2023-05-16 Cerus Endovascular Limited Occlusion device
US10869672B2 (en) 2016-03-11 2020-12-22 Cents Endovascular Limited Occlusion device
US10893869B2 (en) 2016-03-24 2021-01-19 Covidien Lp Thin wall constructions for vascular flow diversion
US11690631B2 (en) 2016-06-21 2023-07-04 Endostream Medical Ltd. Device for restricting blood flow to aneurysms
US10966728B2 (en) 2016-06-21 2021-04-06 Endostream Medical Ltd. Medical device for treating vascular malformations
US10828037B2 (en) 2016-06-27 2020-11-10 Covidien Lp Electrolytic detachment with fluid electrical connection
US10828039B2 (en) 2016-06-27 2020-11-10 Covidien Lp Electrolytic detachment for implantable devices
US11051822B2 (en) 2016-06-28 2021-07-06 Covidien Lp Implant detachment with thermal activation
US10478195B2 (en) 2016-08-04 2019-11-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11376012B2 (en) 2016-08-04 2022-07-05 Covidien Lp Devices, systems, and methods for treatment of vascular defects
US11389170B2 (en) 2016-09-16 2022-07-19 Endoshape, Inc. Occlusive implants with fiber-based release structures
US10576099B2 (en) 2016-10-21 2020-03-03 Covidien Lp Injectable scaffold for treatment of intracranial aneurysms and related technology
US11813282B2 (en) 2016-10-21 2023-11-14 Covidien Lp Injectable scaffold for treatment of intracranial aneurysms and related technology
CN108451569A (en) * 2017-02-21 2018-08-28 科赫里克斯医疗股份有限公司 Medical treatment device for correcting left auricle of heart and relevant system and method
US11890020B2 (en) 2017-02-23 2024-02-06 DePuy Synthes Products, Inc. Intrasaccular aneurysm treatment device with varying coatings
US11672543B2 (en) 2017-02-23 2023-06-13 DePuy Synthes Products, Inc. Aneurysm method and system
EP3403596A1 (en) * 2017-05-16 2018-11-21 Universitätsklinikum Jena Implantation and anchorage system for an atrial occluder
WO2018210907A1 (en) * 2017-05-16 2018-11-22 Universitätsklinikum Jena Implanting and anchoring system for an atrial appendage occlusion device
US11812971B2 (en) 2017-08-21 2023-11-14 Cerus Endovascular Limited Occlusion device
US11304700B2 (en) 2017-08-22 2022-04-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US10675036B2 (en) 2017-08-22 2020-06-09 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11484322B2 (en) 2018-01-03 2022-11-01 Aneuclose Llc Aneurysm neck bridge with a closeable opening or lumen through which embolic material is inserted into the aneurysm sac
US10905430B2 (en) 2018-01-24 2021-02-02 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11672540B2 (en) 2018-01-24 2023-06-13 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11065136B2 (en) 2018-02-08 2021-07-20 Covidien Lp Vascular expandable devices
US11065009B2 (en) 2018-02-08 2021-07-20 Covidien Lp Vascular expandable devices
US11759342B2 (en) 2018-02-08 2023-09-19 Covidien Lp Vascular expandable devices
US11957357B2 (en) 2018-02-08 2024-04-16 Covidien Lp Vascular expandable devices
US11058430B2 (en) 2018-05-25 2021-07-13 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11596412B2 (en) 2018-05-25 2023-03-07 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US10939915B2 (en) 2018-05-31 2021-03-09 DePuy Synthes Products, Inc. Aneurysm device and delivery system
US11583288B2 (en) 2018-08-08 2023-02-21 DePuy Synthes Products, Inc. Delivery of embolic braid
US11793523B2 (en) 2018-08-22 2023-10-24 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
US10905432B2 (en) 2018-08-22 2021-02-02 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
US11812967B2 (en) 2018-08-22 2023-11-14 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
US10912569B2 (en) 2018-08-22 2021-02-09 Covidien Lp Aneurysm treatment coils and associated systems and methods of use
US11123077B2 (en) 2018-09-25 2021-09-21 DePuy Synthes Products, Inc. Intrasaccular device positioning and deployment system
US11076861B2 (en) 2018-10-12 2021-08-03 DePuy Synthes Products, Inc. Folded aneurysm treatment device and delivery method
US11633191B2 (en) 2018-10-12 2023-04-25 DePuy Synthes Products, Inc. Folded aneurysm treatment device and delivery method
US11406392B2 (en) 2018-12-12 2022-08-09 DePuy Synthes Products, Inc. Aneurysm occluding device for use with coagulating agents
US11730485B2 (en) 2018-12-17 2023-08-22 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11278291B2 (en) 2018-12-17 2022-03-22 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11129621B2 (en) 2018-12-17 2021-09-28 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11678887B2 (en) 2018-12-17 2023-06-20 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11324513B2 (en) 2018-12-17 2022-05-10 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11272939B2 (en) 2018-12-18 2022-03-15 DePuy Synthes Products, Inc. Intrasaccular flow diverter for treating cerebral aneurysms
US11812970B2 (en) 2019-01-17 2023-11-14 Endostream Medical Ltd. Vascular-malformation implant system
US11134953B2 (en) 2019-02-06 2021-10-05 DePuy Synthes Products, Inc. Adhesive cover occluding device for aneurysm treatment
US11559309B2 (en) 2019-03-15 2023-01-24 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11317921B2 (en) 2019-03-15 2022-05-03 Sequent Medical, Inc. Filamentary devices for treatment of vascular defects
US11291453B2 (en) 2019-03-15 2022-04-05 Sequent Medical, Inc. Filamentary devices having a flexible joint for treatment of vascular defects
US11337706B2 (en) 2019-03-27 2022-05-24 DePuy Synthes Products, Inc. Aneurysm treatment device
US20200305885A1 (en) * 2019-03-27 2020-10-01 DePuy Synthes Products, Inc. Aneurysm treatment device
US11607226B2 (en) 2019-05-21 2023-03-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device with corrugations
US11497504B2 (en) 2019-05-21 2022-11-15 DePuy Synthes Products, Inc. Aneurysm treatment with pushable implanted braid
US11413046B2 (en) 2019-05-21 2022-08-16 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11672542B2 (en) 2019-05-21 2023-06-13 DePuy Synthes Products, Inc. Aneurysm treatment with pushable ball segment
US11278292B2 (en) 2019-05-21 2022-03-22 DePuy Synthes Products, Inc. Inverting braided aneurysm treatment system and method
US11583282B2 (en) 2019-05-21 2023-02-21 DePuy Synthes Products, Inc. Layered braided aneurysm treatment device
US11202636B2 (en) 2019-05-25 2021-12-21 Galaxy Therapeutics Inc. Systems and methods for treating aneurysms
US10856880B1 (en) 2019-05-25 2020-12-08 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
US11166731B2 (en) 2019-05-25 2021-11-09 Galaxy Therapeutics Inc. Systems and methods for treating aneurysms
US11058431B2 (en) 2019-05-25 2021-07-13 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
US11622771B2 (en) 2019-05-25 2023-04-11 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
US11033277B2 (en) 2019-05-25 2021-06-15 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms
US11369355B2 (en) 2019-06-17 2022-06-28 Coherex Medical, Inc. Medical device and system for occluding a tissue opening and method thereof
US11944314B2 (en) 2019-07-17 2024-04-02 Boston Scientific Scimed, Inc. Left atrial appendage implant with continuous covering
US11540838B2 (en) 2019-08-30 2023-01-03 Boston Scientific Scimed, Inc. Left atrial appendage implant with sealing disk
US11679458B2 (en) 2019-11-04 2023-06-20 Covidien Lp Devices, systems, and methods for treating aneurysms
US11685007B2 (en) 2019-11-04 2023-06-27 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11633818B2 (en) 2019-11-04 2023-04-25 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11717924B2 (en) 2019-11-04 2023-08-08 Covidien Lp Devices, systems, and methods for treatment of intracranial aneurysms
US11602350B2 (en) 2019-12-05 2023-03-14 DePuy Synthes Products, Inc. Intrasaccular inverting braid with highly flexible fill material
US11457926B2 (en) 2019-12-18 2022-10-04 DePuy Synthes Products, Inc. Implant having an intrasaccular section and intravascular section
US11406404B2 (en) 2020-02-20 2022-08-09 Cerus Endovascular Limited Clot removal distal protection methods
US11903589B2 (en) 2020-03-24 2024-02-20 Boston Scientific Scimed, Inc. Medical system for treating a left atrial appendage
US11931041B2 (en) 2020-05-12 2024-03-19 Covidien Lp Devices, systems, and methods for the treatment of vascular defects
US11812969B2 (en) 2020-12-03 2023-11-14 Coherex Medical, Inc. Medical device and system for occluding a tissue opening and method thereof
CN114504356A (en) * 2021-06-23 2022-05-17 上海心玮医疗科技股份有限公司 Three-dimensional self-adaptive intracranial aneurysm plugging device
US11969171B2 (en) 2023-04-10 2024-04-30 Galaxy Therapeutics, Inc. Systems and methods for treating aneurysms

Also Published As

Publication number Publication date
WO2006074032A2 (en) 2006-07-13
US20210052279A1 (en) 2021-02-25
US20190298379A1 (en) 2019-10-03
WO2006074032A3 (en) 2006-10-26
US10265075B2 (en) 2019-04-23
US20130325053A1 (en) 2013-12-05
US20230015848A1 (en) 2023-01-19

Similar Documents

Publication Publication Date Title
US20210052279A1 (en) Intra-aneurysm devices
US8486101B2 (en) Expanding vaso-occlusive device
EP1827251B1 (en) Vaso-occlusive devices comprising complex-shape proximal portion and smaller diameter distal portion
US20100121350A1 (en) Instantaneous mechanical detachment mechanism for vaso-occlusive devices
US8734500B2 (en) Distal detachment mechanisms for vascular devices
US10478192B2 (en) Detachment mechanisms for implantable devices
EP1339358B1 (en) Stent devices with detachable distal and proximal wires
US9314326B2 (en) System and method for retaining vaso-occlusive devices within an aneurysm
EP1845863B1 (en) Porous materials for use in aneurysms
EP3607895B1 (en) Delivery system for embolic braid
US20070078479A1 (en) Self-expanding vaso-occlusive devices with regulated expansion
US20070239194A1 (en) Vaso-occlusive devices having expandable fibers
US20080287982A1 (en) Catheters for electrolytically detachable embolic devices
EP1843710B1 (en) Vaso-occlusive devices including non-biodegradable biomaterials

Legal Events

Date Code Title Description
AS Assignment

Owner name: BOSTON SCIENTIFIC SCIMED, INC., MINNESOTA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PORTER, STEPHEN CHRISTOPHER;TRAN, TRI D.;HO, HAHN;AND OTHERS;REEL/FRAME:016159/0166

Effective date: 20050107

AS Assignment

Owner name: STRYKER CORPORATION, MICHIGAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:025969/0841

Effective date: 20110103

Owner name: STRYKER NV OPERATIONS LIMITED, IRELAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOSTON SCIENTIFIC SCIMED, INC.;REEL/FRAME:025969/0841

Effective date: 20110103

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION

AS Assignment

Owner name: STRYKER MEDTECH LIMITED, MALTA

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER NV OPERATIONS LIMITED;REEL/FRAME:037153/0034

Effective date: 20151013

Owner name: STRYKER EUROPEAN HOLDINGS I, LLC, MICHIGAN

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER MEDTECH LIMITED;REEL/FRAME:037153/0241

Effective date: 20151013

AS Assignment

Owner name: STRYKER EUROPEAN HOLDINGS I, LLC, MICHIGAN

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT LISTED SERIAL NOS. 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0241. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT EFFECTIVE DATE 9/29/2014;ASSIGNOR:STRYKER MEDTECH LIMITED;REEL/FRAME:038043/0011

Effective date: 20151013

Owner name: STRYKER MEDTECH LIMITED, MALTA

Free format text: CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT SERIAL # 09/905,670 AND 07/092,079 PREVIOUSLY RECORDED AT REEL: 037153 FRAME: 0034. ASSIGNOR(S) HEREBY CONFIRMS THE NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER NV OPERATIONS LIMITED;REEL/FRAME:038039/0001

Effective date: 20151013

AS Assignment

Owner name: STRYKER EUROPEAN OPERATIONS HOLDINGS LLC, MICHIGAN

Free format text: CHANGE OF NAME;ASSIGNOR:STRYKER EUROPEAN HOLDINGS III, LLC;REEL/FRAME:052860/0716

Effective date: 20190226

Owner name: STRYKER EUROPEAN HOLDINGS III, LLC, DELAWARE

Free format text: NUNC PRO TUNC ASSIGNMENT;ASSIGNOR:STRYKER EUROPEAN HOLDINGS I, LLC;REEL/FRAME:052861/0001

Effective date: 20200519